| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000259387 uM | Activity at 0.0000710850 uM | Activity at 0.0001271514 uM | Activity at 0.0003024044 uM | Activity at 0.0005030064 uM | Activity at 0.0006524306 uM | Activity at 0.00193 uM | Activity at 0.00341 uM | Activity at 0.00584 uM | Activity at 0.010 uM | Activity at 0.018 uM | Activity at 0.052 uM | Activity at 0.078 uM | Activity at 0.156 uM | Activity at 0.276 uM | Activity at 0.478 uM | Activity at 0.883 uM | Activity at 1.507 uM | Activity at 3.884 uM | Activity at 7.354 uM | Activity at 12.96 uM | Activity at 21.63 uM | Activity at 38.41 uM | Activity at 76.33 uM | Activity at 137.0 uM | Activity at 204.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1 | 104.9664 | 88 | Complete curve; high efficacy | -6 | 3.5117 | 0.6658 | -104.9664 | 0 | -1.1 | 0 0 0 | -97.13 | -85.6484 | -112.8671 | -97.13 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 0.3162 | 59.3278 | 88 | Complete curve; high efficacy | -6.5 | 0.8 | 1 | -84.7193 | -25.3915 | -1.1 | 0 0 0 | -83.9327 | -75.7429 | -81.922 | -83.9327 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inhibitor | 3.1623 | 20.4987 | 85 | Complete curve; high efficacy | -5.5 | 4.9549 | 0.4756 | -107.8212 | -87.3224 | -1.1 | 0 0 0 | -101.1849 | -96.9354 | -114.4343 | -101.1849 | QC'd by SIGMA | ||||||||||||||||||||||||
| Inhibitor | 0.7492 | 66.1511 | 66 | Complete curve; partial efficacy | -6.1254 | 1 | 0.8229 | -74.6135 | -8.4624 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -67.099 | -7.8787 | -22.7216 | -1.4525 | -29.6562 | -23.5194 | -8.332 | -25.0891 | -62.4832 | -68.6466 | -63.9027 | -67.099 | QC'd by Microsource | ||||||||||||||||
| Inhibitor | 1 | 21.6845 | 66 | Complete curve; partial efficacy | -6 | 4.9549 | 0.9699 | -77.7873 | -56.1028 | -1.2 | 0 0 0 | -76.43 | -65.0857 | -78.9894 | -76.43 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inhibitor | 1.122 | 59.6758 | 65 | Complete curve; partial efficacy | -5.95 | 1.21 | 0.9999 | -66.8495 | -7.1736 | -1.2 | 0 0 0 | -66.096 | -42.6313 | -61.4055 | -66.096 | QC'd by Vitas | ||||||||||||||||||||||||
| Inhibitor | 1.9953 | 34.0263 | 64 | Complete curve; partial efficacy | -5.7 | 4.9549 | 0.9891 | -73.9118 | -39.8855 | -1.2 | 0 0 0 | -72.1972 | -47.1162 | -75.3813 | -72.1972 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 12.5893 | 37.2665 | 62 | Complete curve; partial efficacy | -4.9 | 1 | 1 | -78.1117 | -40.8452 | -1.2 | 0 0 0 | -68.8431 | -44.9463 | -54.9089 | -68.8431 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 14.1254 | 32.4297 | 62 | Complete curve; partial efficacy | -4.85 | 1.2216 | 0.9999 | -88.7022 | -56.2725 | -1.2 | 0 0 0 | -81.3177 | -58.1227 | -66.7029 | -81.3177 | QC'd by Enzo | ||||||||||||||||||||||||
| Inhibitor | 10 | 29.8983 | 62 | Complete curve; partial efficacy | -5 | 3.2975 | 0.9999 | -76.1051 | -46.2067 | -1.2 | 0 0 0 | -75.9694 | -46.234 | -54.866 | -75.9694 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 11.2202 | 26.8497 | 61 | Complete curve; partial efficacy | -4.95 | 4.095 | 0.9996 | -65.1082 | -38.2585 | -1.2 | 0 0 0 | -65.0072 | -38.2023 | -43.2866 | -65.0072 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 25.1189 | 45.7844 | 61 | Complete curve; partial efficacy | -4.6 | 1.5386 | 1 | -101.459 | -55.6745 | -1.2 | 0 0 0 | -85.8367 | -56.2934 | -62.0903 | -85.8367 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 31.6228 | 32.298 | 60 | Complete curve; partial efficacy | -4.5 | 2.1876 | 0.9999 | -141.8428 | -109.5448 | -1.2 | 0 0 0 | -129.0357 | -109.6207 | -111.066 | -129.0357 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 31.6228 | 35.9772 | 60 | Complete curve; partial efficacy | -4.5 | 1.1 | 0.9999 | -99.0432 | -63.0659 | -1.2 | 0 0 0 | -82.9526 | -64.2216 | -69.1965 | -82.9526 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 37.6242 | 60 | Complete curve; partial efficacy | -4.45 | 4.9549 | 0.9762 | -81.2779 | -43.6537 | -1.2 | 0 0 0 | -66.0936 | -45.7944 | -41.8015 | -66.0936 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 50.1885 | 60 | Complete curve; partial efficacy | -4.45 | 4.4495 | 0.9982 | -87.6877 | -37.4992 | -1.2 | 0 0 0 | -66.8089 | -38.2236 | -36.8414 | -66.8089 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 47.3405 | 60 | Complete curve; partial efficacy | -4.45 | 4.9549 | 0.9906 | -107.1544 | -59.8139 | -1.2 | 0 0 0 | -87.9757 | -61.3159 | -58.1701 | -87.9757 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||||||
| Inhibitor | 5.9508 | 124.6251 | 45 | Partial curve; high efficacy | -5.2254 | 2.7202 | 0.864 | -126.7319 | -2.1068 | -2.1 | 0 0 0 0 0 0 0 0 0 0 1 | 0 | 0 | 0 | -13.748 | -1.3723 | -25.9483 | -11.2825 | 26.6518 | 8.4521 | -36.83 | -113.8031 | 0 | QC'd by ChemAxon | ||||||||||||||||
| Inhibitor | 11.8734 | 89.5441 | 42 | Partial curve; partial efficacy | -4.9254 | 1.2475 | 0.9863 | -91.1278 | -1.5837 | -2.2 | 0 0 0 0 0 1 0 0 0 0 0 | -74.7046 | 0 | 0 | 0 | -4.6868 | -8.0974 | -38.1516 | 1.1319 | -8.2196 | -21.8072 | -47.3218 | -74.7046 | QC'd by Cayman | ||||||||||||||||
| Inhibitor | 25.1189 | 267.3838 | 41 | Partial curve; partial efficacy | -4.6 | 4.9549 | 0.8835 | -100.7065 | 166.6773 | -2.2 | 0 0 0 | -71.9482 | 116.4983 | 215.4265 | -71.9482 | QC'd by Tocris |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000295000 uM | Activity at 0.0000590000 uM | Activity at 0.0001503265 uM | Activity at 0.0002712146 uM | Activity at 0.0005895491 uM | Activity at 0.00117 uM | Activity at 0.00179 uM | Activity at 0.00299 uM | Activity at 0.00672 uM | Activity at 0.014 uM | Activity at 0.026 uM | Activity at 0.040 uM | Activity at 0.074 uM | Activity at 0.167 uM | Activity at 0.363 uM | Activity at 0.628 uM | Activity at 0.975 uM | Activity at 1.849 uM | Activity at 4.119 uM | Activity at 9.037 uM | Activity at 15.83 uM | Activity at 21.08 uM | Activity at 46.23 uM | Activity at 92.54 uM | Activity at 165.6 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4 | -3.0662 | -2.4126 | 1.9741 | -4.0617 | -0.6298 | -3.0662 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7346 | -0.808 | -4.308 | 4 | 0 0 0 0 0 | -0.431 | -4.308 | 0.8987 | -1.5892 | -1.522 | -0.431 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6448 | -12.5127 | 4.5585 | 4 | 0 0 0 0 0 | -9.7509 | 6.5585 | 1.6006 | -0.8104 | 11.697 | -9.7509 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 18.3564 | 99.0378 | 41 | Partial curve; high efficacy | -4.7362 | 2.8473 | 0.9985 | -99.5803 | -0.5425 | -2.1 | 0 0 0 0 0 | -92.8278 | -1.5772 | -1.9365 | 1.8258 | -13.1847 | -92.8278 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 29.0929 | 42.1815 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9879 | -50.8391 | -8.6577 | -3 | 0 0 0 0 0 | -46.8496 | -7.6387 | -8.6142 | -11.6103 | -6.66 | -46.8496 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 18.3564 | 123.8718 | 41 | Partial curve; high efficacy | -4.7362 | 1.6259 | 0.9975 | -121.4578 | 2.414 | -2.1 | 0 0 0 0 0 | -98.8224 | 5.0098 | -1.1767 | -0.5372 | -27.2941 | -98.8224 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 14.581 | 109.9073 | 42 | Partial curve; high efficacy | -4.8362 | 1.8265 | 0.9637 | -106.4086 | 3.4987 | -2.1 | 0 0 0 0 0 | -94.6709 | 12.0352 | -9.7094 | 6.0901 | -28.9742 | -94.6709 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.9096 | -34.0578 | -3.7697 | 4 | 0 0 0 0 0 | -28.0098 | -7.7697 | -15.2699 | -21.1534 | -19.3019 | -28.0098 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 90.8978 | 10 | Single point of activity | -4.5362 | 4.4495 | 0.9936 | -90.3368 | 0.561 | -3 | 0 0 0 0 0 | -79.9635 | 5.0637 | -2.1732 | -1.6903 | 0.5114 | -79.9635 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.4266 | 15.2787 | -6.7213 | 4 | 0 0 0 0 0 | 10.4803 | -5.7213 | 8.5589 | -5.3046 | 6.719 | 10.4803 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 1.9673 | 0.6089 | -9.5082 | 5.2968 | 4 | 0 0 0 0 0 | -7.9574 | 7.2968 | -1.8903 | 10.3946 | 1.3036 | -7.9574 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 16.3601 | 45.5047 | 10 | Single point of activity | -4.7862 | 4.9549 | 0.9618 | -49.1256 | -3.6209 | -3 | 0 0 0 0 0 | -48.9315 | -7.5358 | -6.333 | 2.7698 | -6.0371 | -48.9315 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | -5.2862 | 0.8 | 0.9747 | -26.7427 | 8.4372 | 4 | 0 0 0 0 0 | -20.7127 | 9.4372 | 2.2965 | 0.248 | -14.6534 | -20.7127 | QC'd by "Chem Div" | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9526 | -10.3928 | 12.1594 | 4 | 0 0 0 0 0 | -10.3008 | 7.6594 | 13.8067 | 14.3816 | -9.7278 | -10.3008 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 2.2526 | 0.9456 | -15.0824 | -3.8247 | 4 | 0 0 0 0 0 | -14.7061 | -2.8247 | -5.6912 | -3.1226 | -9.4063 | -14.7061 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inhibitor | 12.9953 | 78.8447 | 42 | Partial curve; high efficacy | -4.8862 | 1.5579 | 0.9935 | -82.5518 | -3.7072 | -2.1 | 0 0 0 0 0 | -72.8175 | -6.4603 | -0.3489 | -8.7793 | -32.8366 | -72.8175 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inhibitor | 18.3564 | 49.7424 | 10 | Single point of activity | -4.7362 | 2.8473 | 0.9797 | -46.1416 | 3.6008 | -3 | 0 0 0 0 0 | -42.7679 | -0.8992 | 4.983 | 6.9739 | -2.5062 | -42.7679 | QC'd by "Chem Div" | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8308 | -9.799 | 10.4725 | 4 | 0 0 0 0 0 | -5.0871 | 8.4725 | 8.2561 | 10.0709 | 16.081 | -5.0871 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 1.8851 | 0.9722 | -5.7685 | 6.2205 | 4 | 0 0 0 0 0 | -5.063 | 6.2205 | -1.5445 | -7.1037 | -5.5678 | -5.063 | QC'd by "Chem Div" | |||||||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.842 | -31.9249 | 3.174 | 4 | 0 0 0 0 0 | -26.7418 | -0.826 | -13.6909 | -13.1344 | -14.0869 | -26.7418 | QC'd by "Chem Div" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000295000 uM | Activity at 0.0000590000 uM | Activity at 0.0001503265 uM | Activity at 0.0002712146 uM | Activity at 0.0005895491 uM | Activity at 0.00117 uM | Activity at 0.00179 uM | Activity at 0.00299 uM | Activity at 0.00672 uM | Activity at 0.014 uM | Activity at 0.026 uM | Activity at 0.040 uM | Activity at 0.074 uM | Activity at 0.167 uM | Activity at 0.363 uM | Activity at 0.628 uM | Activity at 0.975 uM | Activity at 1.849 uM | Activity at 4.119 uM | Activity at 9.037 uM | Activity at 15.83 uM | Activity at 21.08 uM | Activity at 46.23 uM | Activity at 92.54 uM | Activity at 165.6 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 20.5962 | 118.891 | 41 | Partial curve; high efficacy | -4.6862 | 2.3031 | 0.9994 | -116.1669 | 2.7241 | -2.1 | 0 0 0 0 0 | -99.9451 | 2.7241 | 4.2572 | 0.7717 | -13.7373 | -99.9451 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9749 | -16.1771 | 2.0057 | 4 | 0 0 0 0 0 | -13.1466 | 2.0057 | 1.2486 | -2.8352 | -5.7162 | -13.1466 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6148 | -11.801 | 2.2059 | 4 | 0 0 0 0 0 | -9.7999 | -4.7941 | 3.6452 | 6.7363 | 3.1419 | -9.7999 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | -5.0362 | 2.3332 | 0.9795 | -28.8852 | -5.2723 | 4 | 0 0 0 0 0 | -28.1997 | -7.2723 | -3.3531 | -4.7215 | -17.5124 | -28.1997 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inhibitor | 5.1735 | 94.6885 | 84 | Complete curve; high efficacy | -5.2862 | 2.9023 | 0.9917 | -96.1842 | -1.4957 | -1.1 | 0 0 0 0 0 | -96.0073 | -7.5308 | 4.5779 | -6.8491 | -81.1577 | -96.0073 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inhibitor | 18.3564 | 94.012 | 10 | Single point of activity | -4.7362 | 3.6272 | 0.9999 | -96.5346 | -2.5226 | -3 | 0 0 0 0 0 | -93.107 | -2.9055 | -1.9361 | -2.363 | -9.7613 | -93.107 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8434 | -31.3086 | -2.255 | 4 | 0 0 0 0 0 | -27.0497 | -0.755 | -10.521 | 0.9228 | 0.8125 | -27.0497 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.7303 | -25.728 | -7.2492 | 4 | 0 0 0 0 0 | -25.3982 | -8.7492 | -13.5128 | 0.9177 | -19.0413 | -25.3982 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inhibitor | 20.5962 | 100.5411 | 41 | Partial curve; high efficacy | -4.6862 | 2.0937 | 0.998 | -104.3872 | -3.8461 | -2.1 | 0 0 0 0 0 | -88.9539 | -4.1551 | -2.0443 | -7.1093 | -18.8654 | -88.9539 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inhibitor | 29.0929 | 91.4133 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9947 | -88.3597 | 3.0536 | -3 | 0 0 0 0 0 | -79.845 | -1.1685 | 2.6559 | 4.5385 | 5.7131 | -79.845 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.786 | -1.8499 | 12.9954 | 4 | 0 0 0 0 1 | 16.1947 | 7.9954 | 18.2295 | 0.5262 | -1.8757 | 16.1947 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9259 | -4.5454 | 4.3839 | 4 | 0 0 0 0 0 | -3.7239 | 5.3839 | 4.747 | 2.666 | 4.8335 | -3.7239 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | -6.2362 | 4.9549 | 0.9762 | -1.4086 | 19.4543 | 4 | 0 0 0 0 0 | 1.2086 | 19.4543 | 17.7088 | -3.3481 | -2.3756 | 1.2086 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4363 | -4.5616 | -11.5616 | 4 | 0 0 0 0 0 | -4.5336 | -11.5616 | -1.6565 | -10.5162 | -2.2482 | -4.5336 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.9889 | 6.5184 | -6.9816 | 4 | 0 0 0 0 0 | 2.8921 | -7.4816 | -5.7762 | -3.9537 | -1.5242 | 2.8921 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5926 | -22.1394 | -0.1559 | 4 | 0 0 0 0 0 | -20.8088 | -4.1559 | -8.304 | 12.2914 | -0.0696 | -20.8088 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 64.2186 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9684 | -70.1227 | -5.9041 | -3 | 0 0 0 0 0 | -64.396 | -9.2052 | -0.418 | -11.9994 | -2.9068 | -64.396 | QC'd by "Asinex Ltd." | |||||||||||||||||||||
| Inactive | 0 | 1.21 | 0.9644 | -26.9263 | 4.8437 | 4 | 0 0 0 0 0 | -17.9647 | 6.8437 | 4.9663 | 0.5719 | -1.9517 | -17.9647 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9261 | -29.987 | 1.9364 | 4 | 0 0 0 0 0 | -26.9998 | 0.4364 | -0.7582 | -0.4532 | 7.9656 | -26.9998 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.4576 | 1.7803 | 12.607 | 4 | 0 0 0 0 0 | 6.6132 | 11.107 | -4.9986 | 0.186 | 5.2579 | 6.6132 | QC'd by "Asinex Ltd." |
| Luminescence_A | Luminescence_B | Z-score Rep A | Z-score Rep B |
|---|---|---|---|
| 1508759 | 1941614 | -0.29 | -0.43 |
| 1741176 | 1927012 | -0.01 | -0.44 |
| 1976146 | 2487751 | 0.29 | 0.11 |
| 3470457 | 4045119 | 2.15 | 1.64 |
| 2449298 | 2866419 | 0.88 | 0.48 |
| 1563373 | 2388055 | -0.23 | 0.01 |
| 1827211 | 2429927 | 0.1 | 0.05 |
| 235000 | 430356 | -1.88 | -1.91 |
| 1544315 | 2345114 | -0.25 | -0.03 |
| 1823928 | 2754670 | 0.1 | 0.37 |
| 1077652 | 2101177 | -0.83 | -0.27 |
| 1904653 | 2707288 | 0.2 | 0.33 |
| 3277991 | 3850403 | 1.91 | 1.45 |
| 1695129 | 2723755 | -0.06 | 0.34 |
| 4013685 | 4742114 | 2.82 | 2.33 |
| 2450781 | 3348149 | 0.88 | 0.96 |
| 2531343 | 3071422 | 0.98 | 0.69 |
| 2294937 | 2898722 | 0.68 | 0.52 |
| 1650729 | 2422255 | -0.12 | 0.05 |
| 1212559 | 1703208 | -0.66 | -0.66 |
| OD | %Activity | 384ID |
|---|---|---|
| 0.984 | 97.1319127496888 | TO1A04 |
| 1.004 | 100.68831130342 | TO1A06 |
| 1.06 | 110.646227253868 | TO1A07 |
| 1.023 | 104.066889929465 | TO1A08 |
| 1.025 | 104.422529784838 | TO1A09 |
| 1.032 | 105.667269278644 | TO1A10 |
| 1.019 | 103.355610218718 | TO1A11 |
| 1.059 | 110.468407326181 | TO1A14 |
| 1.049 | 108.690208049315 | TO1A15 |
| 1.044 | 107.801108410883 | TO1A16 |
| 1.047 | 108.334568193942 | TO1A17 |
| 1.054 | 109.579307687748 | TO1A18 |
| 1.137 | 124.338361685733 | TO1A19 |
| 1.109 | 119.359403710509 | TO1A20 |
| 1.089 | 115.803005156778 | TO1A21 |
| 1.097 | 117.22556457827 | TO1A22 |
| 0.989 | 98.0210123881216 | TO1B03 |
| 0.982 | 96.7762728943157 | TO1B04 |
| 0.992 | 98.5544721711813 | TO1B05 |
| 1.016 | 102.822150435659 | TO1B06 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.589 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.4153 | -14.5146 | 1 | 4 | 0 0 0 0 1 | 4.685 | -8.5335 | 0.7807 | 11.3474 | -12.5122 | 4.685 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 12.5893 | 29.2705 | 0 | Single point of activity | -4.9 | 4.9549 | 0.9612 | 31 | 1.7295 | 3 | 0 0 0 0 0 | 30.9001 | -1.4754 | 1.0166 | 5.6243 | 6.6083 | 30.9001 | QC'd by "Microsource" | ||||||||||||||||||||||
| Activator | 8.9125 | 65.9699 | 0 | Partial curve; partial efficacy | -5.05 | 0.6 | 0.9478 | 60.7629 | -5.207 | 2.2 | 0 0 0 0 0 | 46.0767 | -2.3225 | 0.7459 | 18.7564 | 22.5194 | 46.0767 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3508 | -5.4241 | 12 | 4 | 0 0 0 0 0 | 2.824 | 6.9985 | -6.3081 | -17.4367 | -1.0266 | 2.824 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.095 | 0.8518 | -20.6942 | -4.8432 | 4 | 1 0 0 0 0 | -16.9639 | -25.916 | -5.286 | -19.6983 | -24.7451 | -16.9639 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8518 | -16.2964 | 1.5 | 4 | 0 0 0 0 1 | 4.1206 | 1.8961 | -0.6171 | -21.497 | -11.4248 | 4.1206 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 83.6659 | 0 | Partial curve; partial efficacy; poor fit | -5.65 | 0.5 | 0.8806 | 54.0974 | -29.5685 | 2.4 | 0 0 0 0 0 | 44.3794 | -19.3312 | -4.1329 | 18.8496 | 13.5792 | 44.3794 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 81.1747 | 42 | Partial curve; high efficacy | -4.9 | 4.095 | 0.9407 | -88.2352 | -7.0605 | -2.1 | 0 0 0 0 0 | -88.059 | -2.1141 | 2.5457 | -21.0606 | -24.383 | -88.059 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.9754 | 0.5 | 18 | 4 | 0 0 0 0 0 | 0.1686 | 15.5939 | 9.5523 | 5.2389 | 3.3969 | 0.1686 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.516 | 14 | -11.1922 | 4 | 0 0 0 0 0 | 8.9233 | 2.0681 | -9.5798 | -21.4101 | -15.067 | 8.9233 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 111.4578 | 10 | Partial curve; high efficacy; poor fit | -5 | 4.095 | 0.8557 | -88.0204 | 23.4373 | -2.3 | 0 0 0 0 0 | -86.963 | 0.1371 | 16.1149 | 55.0816 | -24.8092 | -86.963 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 12.5893 | 111.8609 | 10 | Single point of activity | -4.9 | 1.3987 | 0.9539 | -66.6934 | 45.1675 | -3 | 0 0 0 0 0 | -51.9056 | 34.8895 | 58.2591 | 32.624 | 3.3045 | -51.9056 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4 | 9.4501 | 23.4721 | 50.1914 | -0.8776 | 27.4967 | 9.4501 | QC'd by "Microsource" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 3.6272 | 0.9908 | -9.6077 | 22.5 | 4 | 0 0 0 0 0 | -9.2564 | 21.9907 | 20.6042 | 24.2232 | 8.6092 | -9.2564 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 0 | Single point of activity | 4.9549 | 0.3547 | 25.2512 | 5 | 3 | 0 0 0 0 1 | 15.4142 | 5.7176 | 6.5342 | 43.2316 | 7.0919 | 15.4142 | QC'd by "Microsource" | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6074 | 7 | 18.5 | 4 | 0 0 0 0 0 | 11.6515 | 12.5897 | 21.5938 | 21.2209 | 4.3118 | 11.6515 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Activator | 2.2387 | 52.7895 | 0 | Partial curve; partial efficacy | -5.65 | 2.2526 | 0.9613 | 44.2358 | -8.5537 | 2.2 | 0 0 0 0 1 | -9.4264 | -2.4981 | -13.182 | 11.9591 | 42.1127 | -9.4264 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.942 | 28 | 1.1909 | 4 | 0 0 0 0 1 | 1.5316 | 4.6729 | 1.2372 | -2.341 | 24.4478 | 1.5316 | QC'd by "Microsource" | ||||||||||||||||||||||||||
| Inhibitor | 35.4813 | 55.7622 | 10 | Single point of activity | -4.45 | 4.9549 | 0.7876 | -42.7915 | 12.9707 | -3 | 0 0 0 0 0 | -30.6839 | 14.5151 | 3.8713 | 4.7738 | 29.0235 | -30.6839 | QC'd by "Microsource" | ||||||||||||||||||||||
| Inhibitor | 35.4813 | 49.2317 | 10 | Single point of activity | -4.45 | 4.4495 | 0.7066 | -51.9324 | -2.7008 | -3 | 0 0 0 0 0 | -40.193 | -17.9891 | 11.8148 | -5.5992 | 0.7455 | -40.193 | QC'd by "Microsource" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000000311 uM | Activity at 0.0000000880 uM | Activity at 0.0000001756 uM | Activity at 0.0000004972 uM | Activity at 0.0000014063 uM | Activity at 0.0000028127 uM | Activity at 0.0000079555 uM | Activity at 0.0000225014 uM | Activity at 0.0000450029 uM | Activity at 0.0001299230 uM | Activity at 0.0003002708 uM | Activity at 0.0008965874 uM | Activity at 0.00268 uM | Activity at 0.00700 uM | Activity at 0.016 uM | Activity at 0.032 uM | Activity at 0.076 uM | Activity at 0.219 uM | Activity at 0.631 uM | Activity at 1.728 uM | Activity at 3.886 uM | Activity at 8.587 uM | Activity at 17.80 uM | Activity at 49.20 uM | Activity at 107.3 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 25.1189 | 46.3945 | 20 | Partial curve; partial efficacy | -4.6 | 2.2526 | 0.9287 | -51.2557 | -4.8612 | -2.2 | 0 0 0 0 0 | -41.1028 | -5.7868 | -8.9838 | -1.9677 | -26.4188 | -41.1028 | QC'd by "BIOMOL" | ||||||||||||||||||||||
| Inactive | 0 | 3.5117 | 0.9435 | 10 | -4.567 | 4 | 0 0 0 0 1 | -5.6299 | -3.6518 | -3.5753 | -4.2225 | 6.795 | -5.6299 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.9376 | 11 | -2.7695 | 4 | 0 0 0 0 1 | -2.8045 | -1.4193 | -3.1412 | -1.9048 | 7.584 | -2.8045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7625 | 1 | -16.7 | 4 | 0 0 0 0 | -0.288 | -12.25 | 5.019 | -2.495 | -0.288 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8335 | 4.5 | -7.0946 | 4 | 0 0 0 0 | 3.0138 | -4.2455 | 6.6652 | 3.4342 | 3.0138 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.993 | 0.5 | -16.2895 | 4 | 0 0 0 0 1 | -17.2531 | -11.9079 | 0.4577 | 0.7459 | 0.1472 | -17.2531 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.989 | -13.9862 | -8.1964 | 4 | 0 0 0 0 | -13.7385 | -8.6044 | -8.0804 | -9.4725 | -13.7385 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8435 | -11.2843 | 4 | 4 | 0 0 0 0 0 | -11.9036 | 3.4878 | 5.2393 | 0.5291 | 5.9839 | -11.9036 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7241 | 0.6 | -14.6999 | 4 | 0 0 0 0 1 | -12.1307 | -11.4165 | -6.1179 | -8.0206 | -2.8333 | -12.1307 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8652 | 1 | -19.7041 | 4 | 0 0 0 0 0 | -4.2947 | -18.0867 | -15.9371 | 4.8395 | 2.1157 | -4.2947 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 14.1254 | 42.1465 | 10 | Single point of activity | -4.85 | 4.9549 | 0.8997 | -40.1465 | 2 | -3 | 0 0 0 0 0 | -41.8192 | -2.393 | 5.1804 | -2.5248 | 4.6867 | -41.8192 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6566 | -10.2454 | 0 | 4 | 0 0 0 0 0 | -10.2045 | -4.5492 | -0.0989 | 4.6103 | -5.6017 | -10.2045 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5279 | 3 | -11.3522 | 4 | 0 0 0 0 | 1.078 | -15.7102 | -2.9932 | -14.9547 | 1.078 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 1.6924 | 0.9123 | 0.5 | -10.147 | 4 | 0 0 0 0 | 0.4297 | -9.2892 | -3.9336 | -3.1566 | 0.4297 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.7886 | 8 | -4.3029 | 4 | 0 0 0 0 0 | 5.7256 | -1.9822 | -4.4191 | -3.8175 | 8.0142 | 5.7256 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.997 | 5.5 | -12.076 | 4 | 0 0 0 1 | -6.5693 | -12.5633 | -7.4947 | 4.9219 | -6.5693 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9232 | -18.4489 | -2.2837 | 4 | 0 0 0 0 | -16.2075 | -1.3456 | -4.9534 | -0.2364 | -16.2075 | QC'd by "Prestwick Chemical; Inc." | |||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9481 | 2 | -17.5643 | 4 | 0 0 0 0 1 | -13.5121 | -12.9703 | 3.6247 | 1.4507 | 0.7522 | -13.5121 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5725 | -10.2193 | 7.5 | 4 | 0 0 0 0 0 | -12.7555 | 5.891 | 7.5423 | -18.5161 | 0.6587 | -12.7555 | QC'd by "Prestwick Chemical; Inc." | ||||||||||||||||||||||||||
| Inhibitor | 31.6228 | 100.7069 | 40 | Partial curve; high efficacy | -4.5 | 3.5722 | 0.9933 | -104.0783 | -3.3715 | -2.1 | 0 0 0 0 0 | -83.3961 | 0.3188 | -7.6251 | -4.9588 | -20.5702 | -83.3961 | QC'd by "BIOMOL" |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.013 uM | Activity at 0.025 uM | Activity at 0.042 uM | Activity at 0.068 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Activator | 112.2018 | 2659.1944 | 100 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9988 | 2689.24 | 30.0456 | 2.1 | 0 0 0 0 0 0 | 2175.7605 | -2.1864 | 18.441 | 20.7973 | 83.3849 | 426.7958 | 2175.7605 | QC'd by Microsource | ||||||||||||||||||||
| Activator | 0.1778 | 128.3128 | 95 | Complete curve; high efficacy | -6.75 | 4.9549 | 0.9927 | 134.4851 | 6.1723 | 1.1 | 0 0 0 0 0 1 | 14.509 | 5.6033 | 24.7938 | 142.7655 | 131.831 | 127.7753 | 14.509 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Activator | 0.4467 | 126.1077 | 91 | Complete curve; high efficacy | -6.35 | 1.8617 | 0.9998 | 123.6363 | -2.4714 | 1.1 | 0 0 0 0 0 1 | 0.2688 | -2.5844 | 7.8161 | 80.257 | 120.2764 | 123.3895 | 0.2688 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Activator | 1.122 | 117.1254 | 90 | Complete curve; high efficacy | -5.95 | 2.2481 | 0.9788 | 132.4265 | 15.3011 | 1.1 | 0 0 0 0 0 | 143.3187 | 15.8094 | 39.5652 | 122.9227 | 119.7824 | 143.3187 | QC'd by Tocris | |||||||||||||||||||||
| Activator | 112.2018 | 1122.1776 | 71 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9983 | 1140.5688 | 18.3912 | 2.1 | 0 0 0 0 0 | 922.7903 | 3.2305 | 7.5889 | 41.6506 | 204.8302 | 922.7903 | QC'd by Timtec | |||||||||||||||||||||
| Activator | 100 | 709.5673 | 58 | Partial curve; high efficacy | -4 | 3.99 | 0.9988 | 700.7079 | -8.8594 | 2.1 | 0 0 0 0 0 0 | 592.8155 | -15.9019 | -8.6532 | 4.5286 | -20.153 | 176.4838 | 592.8155 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 79.4328 | 826.4076 | 57 | Partial curve; high efficacy | -4.1 | 4.095 | 0.9972 | 826.7667 | 0.3591 | 2.1 | 0 0 0 0 0 0 | 665.6736 | -2.5729 | -3.4508 | -16.7617 | 25.5851 | 154.5978 | 665.6736 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||
| Activator | 100 | 589.9325 | 55 | Partial curve; high efficacy | -4 | 3.2475 | 0.984 | 613.2979 | 23.3654 | 2.1 | 0 0 0 0 0 0 | 498.6162 | -5.747 | 1.059 | 37.6543 | 62.5313 | 194.9599 | 498.6162 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 558.6566 | 55 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9992 | 557.2619 | -1.3947 | 2.1 | 0 0 0 0 0 | 448.681 | -6.8565 | -3.8767 | 7.0632 | 81.1858 | 448.681 | QC'd by Vitas | |||||||||||||||||||||
| Activator | 100 | 612.4753 | 55 | Partial curve; high efficacy | -4 | 4.5045 | 0.9972 | 611.2868 | -1.1885 | 2.1 | 0 0 0 0 0 0 | 533.4091 | -10.048 | -5.6002 | -8.2068 | 21.4265 | 142.7223 | 533.4091 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 511.5518 | 53 | Partial curve; high efficacy | -4 | 4.4495 | 0.9965 | 517.5467 | 5.995 | 2.1 | 0 0 0 0 0 0 | 453.9884 | -10.4867 | 10.4448 | 3.9744 | 21.1983 | 121.4017 | 453.9884 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 440.1981 | 52 | Partial curve; high efficacy | -3.95 | 4.095 | 0.9989 | 439.2753 | -0.9228 | 2.1 | 0 0 0 0 0 | 348.6312 | -5.1918 | -3.3018 | 6.9705 | 74.6909 | 348.6312 | QC'd by Sequoia | |||||||||||||||||||||
| Activator | 100 | 497.635 | 52 | Partial curve; high efficacy | -4 | 3.6772 | 0.9977 | 486.8252 | -10.8098 | 2.1 | 0 0 0 0 0 0 | 401.671 | -14.9427 | -21.3461 | -13.1864 | 2.6858 | 130.5049 | 401.671 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 438.5085 | 51 | Partial curve; high efficacy | -4 | 4.9549 | 0.9987 | 437.7956 | -0.7128 | 2.1 | 0 0 0 0 0 0 | 392.29 | -7.2531 | 0.2913 | -4.176 | 9.3666 | 93.145 | 392.29 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 56.2341 | 819.9718 | 50 | Partial curve; high efficacy | -4.25 | 3.2475 | 0.9993 | 802.9227 | -17.049 | 2.1 | 0 0 0 0 0 | 787.1792 | -7.4836 | -10.9833 | -14.2075 | 580.1833 | 787.1792 | QC'd by NCI | |||||||||||||||||||||
| Activator | 112.2018 | 363.641 | 50 | Partial curve; high efficacy | -3.95 | 4.9549 | 0.9972 | 355.9752 | -7.6658 | 2.1 | 0 0 0 0 0 0 | 293.7089 | -16.7363 | 0.4741 | -6.1211 | -4.3689 | 34.2599 | 293.7089 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 112.2018 | 363.0297 | 50 | Partial curve; high efficacy | -3.95 | 4.5045 | 0.9992 | 370.4299 | 7.4002 | 2.1 | 0 0 0 0 0 0 | 299.7006 | 3.6943 | 4.7004 | 13.0282 | 5.8575 | 63.7543 | 299.7006 | QC'd by Pharmacopeia | ||||||||||||||||||||
| Activator | 100 | 295.8134 | 48 | Partial curve; high efficacy | -4 | 3.6272 | 0.9992 | 302.0389 | 6.2255 | 2.1 | 0 0 0 0 0 0 | 251.6991 | 2.6798 | 8.4811 | 8.6778 | 9.6504 | 86.3825 | 251.6991 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 100 | 233.3469 | 46 | Partial curve; high efficacy | -4 | 4.5045 | 0.9961 | 221.7227 | -11.6242 | 2.1 | 0 0 0 0 0 0 | 192.4676 | -6.6471 | -16.5394 | -18.4762 | -5.6031 | 42.3638 | 192.4676 | QC'd by CarsonNewman-SPECS | ||||||||||||||||||||
| Activator | 112.2018 | 234.6061 | 46 | Partial curve; high efficacy | -3.95 | 4.9549 | 0.984 | 235.2356 | 0.6295 | 2.1 | 0 0 0 0 0 0 | 197.0148 | 0.9163 | -4.5136 | 1.9482 | 17.442 | 18.7867 | 197.0148 | QC'd by Pharmacopeia |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.013 uM | Activity at 0.025 uM | Activity at 0.042 uM | Activity at 0.068 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.7824 | 1.5059 | 12.5 | 4 | 0 0 0 0 0 0 | 2.5014 | 8.6579 | 16.7333 | 7.679 | -0.4118 | 3.2398 | 2.5014 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5059 | 2 | 22.5 | 4 | 0 0 0 0 0 0 | 6.2536 | 23.1671 | 31.5741 | 20.3971 | 12.3231 | 23.6931 | 6.2536 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 3.0654 | 0.4875 | 6 | 14 | 4 | 0 0 0 0 0 0 | 7.1178 | 13.8537 | 13.0635 | 10.2396 | 19.9104 | 9.8496 | 7.1178 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8513 | -6.1222 | 14.5 | 4 | 0 0 0 0 0 0 | -2.6019 | 18.6181 | 15.6971 | 11.9589 | 10.6497 | 12.3116 | -2.6019 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.444 | 1 | -8.9353 | 4 | 0 0 0 0 0 0 | 4.128 | -6.6128 | 2.8591 | 5.135 | -4.2457 | -1.6866 | 4.128 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.6078 | 1.5 | 7 | 4 | 0 0 0 0 0 0 | 3.2802 | 4.9355 | 7.5212 | 2.2467 | 1.4536 | 0.7626 | 3.2802 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | 15.8078 | 23.8467 | 15.2102 | 5.4007 | 17.1177 | 11.7038 | 15.8078 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -4.3249 | 4.3564 | 0.9262 | -8.2609 | 6.6136 | 3.2318 | -4.3249 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.386 | 6.5 | 16 | 4 | 0 0 0 0 0 1 | 18.5613 | 14.4696 | 22.6167 | 10.2425 | 16.2585 | 8.0741 | 18.5613 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7935 | 15 | -5.3851 | 4 | 0 0 0 0 0 0 | 16.1015 | -1.1543 | 20.9641 | 12.4561 | 14.2395 | 11.4227 | 16.1015 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.5045 | 0.9473 | 10.5 | 22 | 4 | 0 0 0 0 0 0 | 8.6846 | 21.3965 | 22.3063 | 12.7817 | 10.4065 | 12.724 | 8.6846 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.7228 | 2.6804 | 26 | 4 | 0 0 0 0 0 0 | -2.7663 | 19.5819 | 6.4245 | 5.729 | 8.0359 | 4.8741 | -2.7663 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.861 | 16.5 | 8.5 | 4 | 0 0 0 0 0 1 | 9.315 | 8.5106 | 10.8538 | 6.2271 | 15.3684 | 16.5398 | 9.315 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5741 | 10.5 | 0.7083 | 4 | 0 0 0 0 0 0 | 12.2191 | 4.1249 | -2.3265 | 14.4634 | 3.8399 | 10.7866 | 12.2191 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | 9.7084 | 13.4221 | 8.3748 | 0.3338 | 10.1018 | 18.0457 | 9.7084 | QC'd by Pharmacopeia | |||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4502 | -7.4141 | 8.5 | 4 | 0 0 0 0 0 0 | -4.5118 | 9.0559 | 14.9898 | -2.0146 | 10.2874 | 8.4395 | -4.5118 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6758 | 28 | 0.2443 | 4 | 0 0 0 0 0 0 | 23.0495 | 7.0826 | -6.4631 | 4.1349 | 2.386 | -6.0302 | 23.0495 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4.4495 | 0.7608 | -2.5925 | 6.5 | 4 | 0 0 0 0 0 1 | 8.9695 | 3.4459 | 5.6768 | 9.8855 | -0.0456 | -2.1604 | 8.9695 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 2.6384 | 0.665 | 13.5 | 20 | 4 | 0 0 0 0 0 0 | 13.5742 | 16.0359 | 22.5098 | 21.2723 | 19.3862 | 14.3408 | 13.5742 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inactive | 0 | 4 | -3.2632 | -16.2622 | -13.7616 | -11.6684 | -9.5243 | -17.6211 | -3.2632 | QC'd by Prestwick Chemical; Inc. |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00123 uM | Activity at 0.00246 uM | Activity at 0.00610 uM | Activity at 0.00630 uM | Activity at 0.011 uM | Activity at 0.025 uM | Activity at 0.045 uM | Activity at 0.067 uM | Activity at 0.120 uM | Activity at 0.202 uM | Activity at 0.314 uM | Activity at 0.611 uM | Activity at 1.089 uM | Activity at 1.568 uM | Activity at 3.058 uM | Activity at 5.503 uM | Activity at 7.834 uM | Activity at 15.29 uM | Activity at 27.41 uM | Activity at 39.61 uM | Activity at 75.76 uM | Activity at 149.6 uM | Activity at 201.4 uM | Activity at 319.7 uM | Activity at 605.8 uM | Activity at 817.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 4.9549 | 0.8563 | -9.9979 | -3.182 | 4 | 0 0 0 0 0 0 | -8.823 | -2.9167 | -5.5515 | -1.8183 | -11.2482 | -10.2408 | -8.823 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 1.5386 | 0.564 | 4 | -4.8546 | 4 | 0 0 0 0 0 1 | -7.5471 | -0.6835 | -9.0455 | -3.7039 | -1.1903 | 3.153 | -7.5471 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.431 | -21.0949 | 2.1993 | 4 | 0 0 0 0 0 0 | -29.6624 | -1.0839 | -27.7771 | -29.2982 | -9.5254 | -9.846 | -29.6624 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.3341 | -1.3603 | -6.9124 | 4 | 0 0 0 0 0 1 | -15.5699 | -9.927 | -2.5767 | -5.8552 | -8.5221 | -2.3836 | -15.5699 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.8913 | 14.1351 | 0 | Complete curve; partial efficacy; poor fit | -6.05 | 2.1211 | 0.6534 | -22.6728 | -8.5377 | -1.4 | 0 0 0 0 0 0 | -21.1521 | -8.7814 | -12.9514 | -21.2535 | -30.9774 | -17.0722 | -21.1521 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 3.132 | 0.4725 | 0.5 | -4.2284 | 4 | 0 0 0 0 0 0 | -0.2612 | -1.9763 | -2.0592 | -8.107 | -2.1288 | 0.8201 | -0.2612 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4917 | -10.967 | -2.3149 | 4 | 0 0 0 0 0 0 | -10.1405 | -1.5124 | -2.5506 | -5.4129 | -17.8892 | -4.0897 | -10.1405 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 3.99 | 0.5924 | -19.9348 | 0 | 4 | 0 0 0 0 0 0 | -28.6957 | -6.2302 | 5.7918 | -15.0449 | -23.6413 | -7.309 | -28.6957 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.4102 | -6.1308 | 5 | 4 | 0 0 0 0 0 0 | -4.355 | 0.8289 | 8.6021 | -2.8349 | -16.359 | 2.161 | -4.355 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.369 | -1.5 | -14.3369 | 4 | 0 0 0 0 0 1 | -9.3021 | -12.7808 | 2.0015 | -0.2528 | -12.5875 | 4.4401 | -9.3021 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.7079 | 23.6221 | 0 | Complete curve; partial efficacy; poor fit | -6.15 | 3.0654 | 0.6513 | -24.5288 | -0.9067 | -1.4 | 0 0 0 0 0 1 | -13.9864 | -1.5889 | -9.6741 | -27.4469 | -33.3677 | -12.1786 | -13.9864 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 4 | -22.4775 | -11.6889 | -11.6628 | -13.5576 | -20.9035 | -8.6191 | -22.4775 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0.8 | 0.7088 | -25.4933 | -11.6918 | 4 | 0 0 0 0 0 0 | -24.5778 | -16.5266 | -8.0765 | -17.2318 | -20.0221 | -22.1348 | -24.5778 | QC'd by Microsource | |||||||||||||||||||||||||
| Inhibitor | 0.1778 | 19.9985 | 0 | Complete curve; partial efficacy; poor fit | -6.75 | 4.9549 | 0.6578 | -21.9347 | -1.9361 | -1.4 | 0 0 0 0 0 0 | -23.6561 | -4.5301 | -30.7789 | -20.7284 | -19.2667 | -15.4849 | -23.6561 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | 1 | 0.9184 | -24.9585 | -2.7331 | 4 | 0 0 0 0 0 1 | -15.8401 | -9.7776 | -20.4013 | -20.4952 | -26.2154 | -25.1202 | -15.8401 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4 | -16.8662 | -15.0798 | -16.9114 | -17.163 | -13.1564 | -16.5558 | -16.8662 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 7.7575 | 3.3126 | 6.1383 | 6.2047 | -2.0209 | 6.2212 | 7.7575 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 3.7597 | 9.7909 | 7.0224 | 3.0975 | -6.8965 | 12.3146 | 3.7597 | QC'd by Microsource | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6335 | -4.9129 | 6 | 4 | 0 0 0 0 0 0 | -8.8467 | 6.1191 | 5.3496 | 5.0731 | -9.0941 | 2.984 | -8.8467 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7097 | -7.2734 | 0 | 4 | 0 0 0 0 0 0 | -5.915 | 1.1538 | -1.0587 | 0.2688 | -11.4778 | -4.1213 | -5.915 | QC'd by Microsource |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0009200000 uM | Activity at 0.00184 uM | Activity at 0.00456 uM | Activity at 0.00471 uM | Activity at 0.00850 uM | Activity at 0.018 uM | Activity at 0.034 uM | Activity at 0.050 uM | Activity at 0.090 uM | Activity at 0.151 uM | Activity at 0.235 uM | Activity at 0.457 uM | Activity at 0.814 uM | Activity at 1.171 uM | Activity at 2.284 uM | Activity at 4.113 uM | Activity at 5.853 uM | Activity at 11.42 uM | Activity at 20.49 uM | Activity at 29.59 uM | Activity at 56.64 uM | Activity at 111.7 uM | Activity at 150.6 uM | Activity at 238.8 uM | Activity at 452.6 uM | Activity at 611.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 3.6272 | 0.8626 | -16.9749 | 3 | 4 | 0 0 0 0 0 0 | -11.3522 | 4.4122 | -0.1869 | 3.8551 | -9.0486 | -22.4791 | -11.3522 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 1.21 | 0.9115 | 1 | 26.5 | 4 | 0 0 0 0 0 0 | 3.0879 | 22.5222 | 31.9661 | 22.8496 | 17.2717 | 6.5589 | 3.0879 | QC'd by NCI | |||||||||||||||||||||||||
| Inactive | 0 | 0.3 | 0.7243 | -12.8995 | 38 | 4 | 0 0 0 0 0 0 | -10.7496 | 28.5168 | 21.9546 | 5.2096 | 6.0738 | 11.3009 | -10.7496 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8029 | -15.6993 | -1.5 | 4 | 0 0 0 0 0 0 | -11.416 | -1.5504 | -1.249 | -4.6581 | -0.4266 | 0.4639 | -11.416 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6678 | -24.4602 | 3.4359 | 4 | 0 0 0 0 0 1 | -5.4651 | 2.872 | 2.434 | -38.4104 | -25.2406 | -9.2436 | -5.4651 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 2.4064 | 0.4215 | 1 | 17 | 4 | 0 0 0 0 0 0 | 5.8729 | 19.3202 | 14.8828 | 8.6332 | 24.907 | 11.2979 | 5.8729 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 0.6 | 0.7078 | -8.3138 | 14.5 | 4 | 0 0 0 0 0 0 | -10.7777 | 11.8187 | 1.9932 | 1.9062 | -11.5115 | -0.0866 | -10.7777 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 3.99 | 0.916 | 12.5 | 29 | 4 | 0 0 0 0 0 0 | 11.3216 | 25.3511 | 10.2782 | 12.6928 | 12.0425 | 15.0596 | 11.3216 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7598 | -8.0307 | 2 | 4 | 0 0 0 0 0 0 | -6.9632 | -1.9133 | 5.8317 | -9.609 | -8.7246 | -6.018 | -6.9632 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.6402 | -18.8089 | -2.3735 | 4 | 0 0 0 0 0 0 | -14.8407 | -3.9662 | -6.7181 | -0.3112 | -9.968 | -9.2615 | -14.8407 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9739 | -11.7501 | 2 | 4 | 0 0 0 0 0 0 | -11.6929 | 3.078 | 0.2437 | 2.2683 | -12.7084 | -10.568 | -11.6929 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | 0.5 | 0.7605 | -11.0605 | 6 | 4 | 0 0 0 0 0 0 | -14.6337 | 3.6876 | -3.5123 | -6.8473 | -7.5675 | -5.2666 | -14.6337 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 4 | -7.53 | 4.7778 | -6.7829 | -15.1322 | -23.649 | 9.0847 | -7.53 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.6409 | -3.2949 | 14 | 4 | 0 0 0 0 0 1 | 12.9818 | 17.651 | 4.102 | 20.6219 | 2.497 | -3.5791 | 12.9818 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 1.8265 | 0.7407 | -32.7287 | -10.9373 | 4 | 0 0 0 0 0 0 | -28.3802 | -13.7631 | -19.1044 | -5.7811 | -12.8137 | -32.2739 | -28.3802 | QC'd by Tocris | |||||||||||||||||||||||||
| Activator | 39.8107 | 46.538 | 0 | Single point of activity | -4.4 | 4.4495 | 0.7454 | 56.6458 | 10.1078 | 3 | 0 0 0 0 0 1 | 17.1415 | 13.5032 | 25.5832 | 14.464 | 6.9538 | 49.1102 | 17.1415 | QC'd by SigmaAldrich | |||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.5359 | -17.7206 | 3.5 | 4 | 0 0 0 0 0 0 | -16.8505 | -6.866 | 13.1002 | -5.4009 | 12.3928 | -11.0619 | -16.8505 | QC'd by SigmaAldrich | |||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.657 | 1.1082 | 10.5 | 4 | 0 0 0 0 0 1 | 10.7172 | 11.3518 | 5.1253 | 15.2488 | -0.3265 | 2.2476 | 10.7172 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.842 | -14.4407 | 10.5 | 4 | 0 0 0 0 0 0 | -8.7006 | 13.0238 | 6.2792 | 7.2892 | 3.5691 | 0.9878 | -8.7006 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | 1.01 | 0.8718 | 2.4065 | -26.9475 | 4 | 0 0 0 0 0 1 | -20.1909 | -25.9748 | -30.373 | -20.9376 | -21.2882 | -7.9946 | -20.1909 | QC'd by Prestwick Chemical; Inc. |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | = | 0.24 | % |
| Inhibition | = | 4.58 | % |
| Inhibition | = | -0.3 | % |
| Inhibition | = | -0.3 | % |
| Inhibition | = | -0.04 | % |
| Inhibition | = | -0.04 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | 0.03 | % |
| Inhibition | = | 0 | % |
| Inhibition | = | 0.03 | % |
| Inhibition | = | 0 | % |
| Inhibition | = | -0.27 | % |
| Inhibition | = | -0.27 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | -0.08 | % |
| Inhibition | = | 14.41 | % |
| Inhibition | = | 0.39 | % |
| COMT-Max_Response | GAMT-Max_Response | GNMT-Max_Response | HNMT-Max_Response | NNMT-Max_Response | PNMT-Max_Response |
|---|---|---|---|---|---|
| -14.477 | -0.906 | -64.36 | -7.723 | -13.221 | -6.568 |
| -97.283 | -96.83 | -99.246 | -99.097 | ||
| -11.662 | -7.108 | -69.542 | -15.105 | -18.57 | -11.209 |
| 9.957 | -8.37 | -63.807 | -27.029 | -13.633 | -0.512 |
| -1.378 | 8.081 | -1.801 | -70.001 | -9.255 | -2.174 |
| -4.184 | -8.838 | -45.186 | -20.976 | -17.93 | -50.762 |
| -64.186 | -17.487 | -82.517 | -23.323 | -14.889 | -4.424 |
| -28.27 | -13.82 | -44.132 | -13.042 | -22.645 | -61.981 |
| -95.918 | 6.395 | -70.15 | 8.26 | -8.601 | -15.867 |
| -6.36 | 6.696 | -61.419 | 10.286 | -22.134 | -20.539 |
| 2.764 | 9.187 | -5.28 | 1.889 | -50.646 | 3.945 |
| 5.46 | 7.241 | -52.163 | 2.748 | -5.368 | 4.271 |
| 18.645 | -5.1 | -85.869 | -4.465 | 17.42 | |
| -33.223 | -8.861 | -69.978 | -8.649 | -22.429 | -13.542 |
| -22.681 | -17.904 | -81.69 | -53.866 | -21.453 | -18.314 |
| 3.649 | -5.536 | -6.193 | -64.526 | -18.858 | -7.356 |
| -17.938 | -19.922 | -61.7 | -32.188 | -41.884 | -42.419 |
| -0.033 | 6.877 | 8.069 | -87.187 | -3.608 | 2.522 |
| 66.248 | 12.293 | -50.945 | -8.947 | -3.843 | 7.458 |
| -0.714 | 0.817 | -11.379 | -86.711 | -10.789 | -2.627 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| 1000000000 | IC50 | < | 1000000000000 | nM | Outside typical range |
| 79432800000 | IC50 | = | 7.94328234724282E13 | nM | Outside typical range |
| 1000000000 | IC50 | < | 1000000000000 | nM | Outside typical range |
| 1258930000000 | IC50 | = | 1.25892541179417E15 | nM | Outside typical range |
| 316228000000 | IC50 | = | 316227766016838 | nM | Outside typical range |
| 1584890000000 | IC50 | = | 1.58489319246111E15 | nM | Outside typical range |
| Phenotype | Potency | Efficacy | Analysis Comment | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003270000 uM | Activity at 0.0007732774 uM | Activity at 0.00163 uM | Activity at 0.00369 uM | Activity at 0.00818 uM | Activity at 0.020 uM | Activity at 0.030 uM | Activity at 0.047 uM | Activity at 0.101 uM | Activity at 0.151 uM | Activity at 0.243 uM | Activity at 0.477 uM | Activity at 0.759 uM | Activity at 1.287 uM | Activity at 2.393 uM | Activity at 3.818 uM | Activity at 6.336 uM | Activity at 11.99 uM | Activity at 19.37 uM | Activity at 31.37 uM | Activity at 60.11 uM | Activity at 107.2 uM | Activity at 158.4 uM | Activity at 229.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 4 | 0 0 0 0 0 | 1.4694 | -3.5669 | -6.235 | 2.8586 | 1.8042 | 1.4694 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -4.2631 | 8.2218 | 8.0811 | 10.2927 | -3.9947 | -4.2631 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 6.0369 | 0.3398 | -2.1048 | -8.1695 | -3.6822 | 6.0369 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -2.0565 | 1.7294 | -3.5894 | -1.2575 | -0.5402 | -2.0565 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | 2.3149 | 1.0048 | 4.6369 | -1.9963 | -3.3543 | 2.3149 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 7.2748 | 7.1515 | 6.1372 | 1.5197 | 5.2332 | 7.2748 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.006 | -3.3873 | -7.786 | -9.3037 | -9.1761 | 1.006 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -0.0368 | -9.4458 | -10.5155 | -9.0065 | -12.9141 | -0.0368 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 2.6 | -7.8084 | -12.3007 | -2.0954 | -6.6887 | 2.6 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -11.4867 | -18.9051 | -17.4955 | -19.0735 | -9.6682 | -11.4867 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | -7.5605 | -17.2173 | -11.0038 | -16.5656 | -22.4025 | -7.5605 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | -7.5451 | -1.1939 | -1.3084 | -5.8268 | -5.3206 | -7.5451 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -5.5852 | -4.3753 | -1.0046 | -3.1641 | -10.1524 | -5.5852 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 0 | 1.1172 | -6.0391 | 7.0118 | 9.0446 | 1.6533 | 1.1172 | QC'd by "Chem Div" | ||||||||||||||||||||||||||||
| Inactive | 4 | 2.3359 | 1.2518 | 1.6626 | -0.9325 | -0.9194 | 2.3359 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 | -19.5354 | 0.3984 | -4.1147 | 2.1883 | -19.5354 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -5.6552 | -4.6769 | -1.9378 | -0.5867 | -3.224 | -5.6552 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -11.3738 | -10.4148 | -13.8912 | -10.4252 | -7.8961 | -11.3738 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | -6.1571 | -8.7102 | -2.9113 | -5.2229 | -3.4369 | -6.1571 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||
| Inactive | 4 | 0 0 0 0 1 | -7.3803 | -8.8177 | -11.1654 | -6.5301 | -15.9483 | -7.3803 | QC'd by "Chem Div" |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | -11.52 | % | Outside typical range |
| Inhibition | = | 5.09 | % | |
| Inhibition | = | -1.71 | % | |
| Inhibition | = | 3.69 | % | |
| Inhibition | = | 22.47 | % | |
| Inhibition | = | 8.51 | % | |
| Inhibition | = | -6.86 | % | |
| Inhibition | = | -6.18 | % | |
| Inhibition | = | -2.07 | % | |
| Inhibition | = | 3.91 | % | |
| Inhibition | = | -5.9 | % | |
| Inhibition | = | -2.45 | % | |
| Inhibition | = | -5.55 | % | |
| Inhibition | = | 6.31 | % | |
| Inhibition | = | -1.08 | % | |
| Inhibition | = | 12.7 | % | |
| Inhibition | = | 0.37 | % | |
| Inhibition | = | 8.88 | % | |
| Inhibition | = | 11.63 | % | |
| Inhibition | = | -1.96 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 9.3597 | 0 | 0 | 0 | 0 | 0 | 2.2289 | 0 | 9.3597 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.8748 | -21.4867 | 4 | 4 | 0 0 0 0 0 0 0 0 | -17.0722 | 6.1042 | 2.8293 | 0 | 7.4025 | 0 | 6.1286 | 5.2151 | -17.0722 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -8.275 | 1.1705 | 0.6611 | 2 | -6.667 | 4 | 0 0 0 0 0 0 0 0 | -1.0776 | -6.3892 | -2.9698 | -1.7372 | 5.874 | 0.3532 | 2.419 | 2.3477 | -1.0776 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | -4.425 | 4.9549 | 0.4933 | -23.5282 | -3 | 4 | 0 0 0 0 0 0 0 0 | -17.9402 | 0.3948 | -8.1012 | -10.4184 | -5.5544 | 1.8102 | -4.7765 | 5.7051 | -17.9402 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 7.8331 | 0 | 0 | 9.3496 | 0 | 8.3936 | 8.8574 | 0 | QC'd by Sequoia | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.1346 | 2.0873 | 2.8787 | 2.1981 | 0 | 1.0717 | 0 | 0 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.7477 | 0 | 7.719 | 6.3706 | 0 | 0 | 0 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3259 | 8.1273 | 0 | 0 | 7.3085 | 6.1485 | 9.7634 | 0 | 1.3259 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -6.775 | 4.9549 | 0.7871 | -25.4234 | -14.7892 | 4 | 1 0 0 0 0 0 0 1 | -14.8266 | -40.4001 | -18.8558 | -14.3881 | -11.9076 | -28.2695 | -23.675 | -23.6904 | -14.8266 | QC'd by Microsource | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 3.2238 | 5.3823 | 0 | 7.5034 | 0 | 0 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.4377 | -10.0741 | 2 | 4 | 0 0 0 0 0 0 0 0 | -7.9784 | 0 | 0 | 6.8904 | -2.1283 | 0 | 0.7614 | 9.8865 | -7.9784 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1184 | 4.7394 | 4.4107 | -0.6138 | 5.1674 | 0 | 2.3218 | -1.3941 | -2.1184 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0.2342 | 2.9725 | 5.1318 | 0 | 2.0235 | 0 | 0.0589 | 0 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -8.725 | 0.6 | 0.7945 | 4.5 | -11.9886 | 4 | 0 0 0 0 0 0 0 1 | -9.0185 | -8.3238 | -0.4567 | 0.9031 | 0.0721 | 3.3394 | 7.7262 | 3.0826 | -9.0185 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -9.125 | 4.9549 | 0.5569 | 5 | -5.3552 | 4 | 0 0 0 0 0 0 0 1 | -2.6103 | -2.796 | 6.9995 | 3.4228 | 1.6101 | 8.0983 | 7.0134 | 2.0138 | -2.6103 | QC'd by Specs | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.9896 | 0 | 0 | 9.6344 | 0 | 0 | 4.2786 | 0 | 0.9896 | QC'd by GVK | ||||||||||||||||||||||||||
| Inactive | 0 | -5.525 | 4.095 | 0.6337 | -3.6963 | 3 | 4 | 0 0 0 0 0 0 0 0 | -3.4671 | 3.2926 | 6.7211 | 0 | 4.9171 | 0 | 2.2046 | -3.4969 | -3.4671 | QC'd by Prestwick | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.1269 | 3.0732 | 0 | 6.5383 | 2.8274 | 0 | -3.4128 | 8.3114 | 3.1269 | QC'd by Labotest | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 2.578 | 6.6592 | 0 | 0 | 0 | 3.3663 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6761 | 0 | 0 | 8.9375 | 0 | 0 | 0.408 | 0 | 2.6761 | QC'd by Prestwick Chemical; Inc. |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.0015 | 95.0131 | 100 | Complete curve; high efficacy | -8.8295 | 4.9549 | 0.995 | -92.9859 | 2.0272 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.2587 | -1.6791 | -84.9271 | -90.9202 | -90.8631 | -90.7375 | -92.2911 | -92.6732 | -94.1019 | -94.0673 | -96.0913 | -96.2587 | QC'd by SIGMA | ||||||||||||||||
| Inhibitor | 0.0017 | 96.0144 | 100 | Complete curve; high efficacy | -8.7683 | 3.2475 | 0.9987 | -95.3786 | 0.6358 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9294 | 1.7123 | -0.1391 | -34.4453 | -93.3159 | -93.9442 | -94.1795 | -94.3745 | -94.7424 | -94.9325 | -95.6129 | -96.9294 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0017 | 101.1335 | 100 | Complete curve; high efficacy | -8.7683 | 4.5045 | 0.9988 | -96.4557 | 4.6778 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.6254 | 2.9383 | 5.3252 | -23.8352 | -93.6078 | -94.3407 | -94.7755 | -96.5382 | -96.9802 | -98.093 | -97.488 | -98.6254 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0014 | 95.7664 | 100 | Complete curve; high efficacy | -8.8683 | 3.0654 | 0.9932 | -91.7312 | 4.0352 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3736 | 0 | 6.5073 | -50.3576 | -85.2142 | -89.4583 | -90.3553 | -90.6328 | -93.2878 | -91.6178 | -92.6738 | -94.3736 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0027 | 92.0567 | 99 | Complete curve; high efficacy | -8.575 | 3.99 | 0.9971 | -93.082 | -1.0254 | -1.1 | 0 0 0 0 0 0 0 0 | -97.5703 | -1.153 | -56.5542 | -91.9507 | -92.331 | -93.0234 | -92.9105 | -92.2466 | -97.5703 | QC'd by Alfa Aesar | |||||||||||||||||||
| Inhibitor | 0.0027 | 86.1528 | 99 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9984 | -92.0573 | -5.9045 | -1.1 | 0 0 0 0 0 0 0 0 | -92.9872 | -5.0961 | -62.3948 | -91.5014 | -91.2009 | -92.0539 | -90.8793 | -91.9519 | -92.9872 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.0021 | 98.4878 | 99 | Complete curve; high efficacy | -8.675 | 4.5045 | 0.9983 | -91.9795 | 6.5083 | -1.1 | 0 0 0 0 0 0 0 0 | -94.0485 | 5.8681 | -73.3835 | -89.9758 | -90.798 | -91.9458 | -91.2065 | -93.7497 | -94.0485 | QC'd by Bosche | |||||||||||||||||||
| Inhibitor | 7.0E-4 | 82.7334 | 99 | Complete curve; high efficacy | -9.175 | 0.6 | 0.8847 | -82.6567 | 0.0767 | -1.1 | 0 0 0 0 0 0 0 0 | -94.3569 | -37.5208 | -62.7186 | -72.7916 | -74.3825 | -79.8918 | -76.6331 | -78.5528 | -94.3569 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0037 | 95.0819 | 99 | Complete curve; high efficacy | -8.4362 | 1.2221 | 0.9994 | -94.5205 | 0.5614 | -1.1 | 0 0 0 0 0 0 0 | -93.7704 | -1.1631 | 0.6157 | -11.9264 | -47.6173 | -82.383 | -92.7843 | -93.7704 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 0.0033 | 94.0479 | 99 | Complete curve; high efficacy | -8.4795 | 3.5117 | 0.9958 | -93.9623 | 0.0856 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.8774 | 1.2665 | -23.1756 | -88.8678 | -90.2585 | -91.8229 | -92.3997 | -94.1271 | -95.2991 | -93.6757 | -95.8566 | -97.8774 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0047 | 102.0075 | 98 | Complete curve; high efficacy | -8.3295 | 2.2481 | 0.997 | -94.1763 | 7.8312 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.7173 | 5.6987 | -9.7434 | -65.3554 | -90.638 | -91.2058 | -92.371 | -92.7427 | -94.2549 | -94.3053 | -96.979 | -98.7173 | QC'd by GVK | ||||||||||||||||
| Inhibitor | 0.0047 | 100.429 | 98 | Complete curve; high efficacy | -8.325 | 3.6772 | 0.9994 | -93.2276 | 7.2013 | -1.1 | 0 0 0 0 0 0 0 0 | -94.7435 | 8.1328 | -8.6557 | -90.5176 | -92.1158 | -93.5383 | -93.4255 | -92.4974 | -94.7435 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 0.0038 | 96.7634 | 98 | Complete curve; high efficacy | -8.425 | 3.99 | 0.9994 | -92.0205 | 4.743 | -1.1 | 0 0 0 0 0 0 0 0 | -93.5167 | 4.0536 | -21.1619 | -91.8053 | -91.1174 | -91.9789 | -90.7784 | -91.2901 | -93.5167 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0045 | 90.5397 | 98 | Complete curve; high efficacy | -8.3466 | 4.5045 | 0.9995 | -92.4565 | -1.9167 | -1.1 | 0 0 0 0 0 0 0 | -93.156 | -4.128 | -89.5728 | -91.2217 | -93.3904 | -92.524 | -93.0057 | -93.156 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.2987 | 98 | Complete curve; high efficacy | -8.288 | 4.9549 | 0.9993 | -92.6581 | 5.6406 | -1.1 | 0 0 0 0 0 0 0 | -93.5941 | 0 | -91.9394 | -91.381 | -91.3804 | -93.5391 | -93.3571 | -93.5941 | QC'd by ChemieTek | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.8546 | 98 | Complete curve; high efficacy | -8.288 | 0.6 | 0.9861 | -94.1197 | 4.7349 | -1.1 | 0 0 0 0 0 0 0 | -93.9318 | -33.6729 | -64.3585 | -76.1096 | -84.2151 | -92.4038 | -93.1111 | -93.9318 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 0.004 | 86.0426 | 98 | Complete curve; high efficacy | -8.3992 | 4.5045 | 0.9996 | -92.288 | -6.2454 | -1.1 | 0 0 0 0 0 0 0 | -91.795 | -7.0299 | -86.4668 | -91.4418 | -93.2202 | -92.6549 | -92.4417 | -91.795 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0046 | 98.0203 | 98 | Complete curve; high efficacy | -8.338 | 3.5117 | 0.9996 | -93.1684 | 4.8519 | -1.1 | 0 0 0 0 0 0 0 | -93.7644 | -11.8828 | -91.4502 | -92.2553 | -94.1095 | -92.9439 | -93.2642 | -93.7644 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 0.0042 | 104.4497 | 98 | Complete curve; high efficacy | -8.3795 | 4.9549 | 0.9968 | -93.9204 | 10.5293 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.6259 | 8.6675 | 7.5142 | -90.2575 | -91.0844 | -91.1114 | -92.6871 | -93.2743 | -95.4523 | -94.079 | -95.5345 | -96.6259 | QC'd by BioAustralis | ||||||||||||||||
| Inhibitor | 0.0042 | 94.9421 | 98 | Complete curve; high efficacy | -8.3795 | 2.8473 | 0.9968 | -94.7591 | 0.183 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9399 | 0.6808 | -16.1375 | -78.234 | -91.1234 | -91.9081 | -92.3507 | -95.4781 | -97.4887 | -95.7111 | -95.4747 | -96.9399 | QC'd by ActiveBioChem |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.008 | 82.2034 | 84 | Complete curve; high efficacy | -8.0992 | 1.01 | 0.9669 | 21.0427 | 103.2462 | -1.1 | 0 0 0 0 0 0 0 | 13.1884 | 95.4748 | 59.0672 | 35.8423 | 31.6652 | 21.9238 | 22.0706 | 13.1884 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 81.0572 | 83 | Complete curve; high efficacy | -7.5862 | 4.9549 | 0.923 | 16.4972 | 97.5544 | -1.1 | 0 0 0 0 0 0 0 | 2.5125 | 97.0035 | 93.2685 | 8.947 | 36.6707 | 23.4209 | 12.5374 | 2.5125 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.8199 | 85.2901 | 83 | Complete curve; high efficacy | -6.0862 | 1.7529 | 0.994 | 32.3577 | 117.6478 | -1.1 | 0 0 0 0 0 0 0 | 34.7953 | 115.2038 | 115.6711 | 122.13 | 98.3734 | 49.1232 | 31.0106 | 34.7953 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.01 | 90.4383 | 83 | Complete curve; high efficacy | -7.9992 | 1.0641 | 0.9856 | 19.9781 | 110.4164 | -1.1 | 0 0 0 0 0 0 0 | 13.8267 | 101.7041 | 71.2241 | 35.8056 | 28.6279 | 25.0828 | 19.4787 | 13.8267 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0092 | 105.8361 | 83 | Complete curve; high efficacy | -8.0362 | 4.095 | 0.9984 | 16.204 | 122.0401 | -1.1 | 0 0 0 0 0 0 0 | 13.8473 | 120.9689 | 28.8486 | 18.131 | 17.3683 | 17.3537 | 14.6878 | 13.8473 | QC'd by SIGMA | ||||||||||||||||||||
| Cytotoxic | 0.4683 | 84.0955 | 83 | Complete curve; high efficacy | -6.3295 | 4.4495 | 0.969 | 29.5128 | 113.6083 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.2667 | 108.9911 | 100.6389 | 111.6185 | 114.5273 | 123.8697 | 121.8467 | 50.4844 | 36.163 | 35.4913 | 26.9501 | 21.2667 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.1048 | 82.7642 | 82 | Complete curve; high efficacy | -6.9795 | 1.4163 | 0.9838 | 12.6322 | 95.3964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.5755 | 88.3117 | 93.0926 | 98.2096 | 96.7434 | 61.0096 | 38.8636 | 20.851 | 15.783 | 15.7035 | 9.9048 | 10.5755 | QC'd by BIOMOL | ||||||||||||||||
| Cytotoxic | 0.1778 | 91.155 | 82 | Complete curve; high efficacy | -6.75 | 0.6 | 0.9671 | 13.9433 | 105.0983 | -1.1 | 0 0 0 0 0 0 0 | 9.949 | 96.7816 | 88.0056 | 52.4837 | 44.6307 | 29.7677 | 23.4253 | 9.949 | QC'd by Waterstone | ||||||||||||||||||||
| Cytotoxic | 0.0106 | 101.8256 | 82 | Complete curve; high efficacy | -7.975 | 2.7202 | 0.9927 | 11.1635 | 112.9891 | -1.1 | 0 0 0 0 0 0 0 0 | 10.2995 | 105.5432 | 116.5795 | 42.3861 | 10.2101 | 10.8286 | 11.4633 | 11.6468 | 10.2995 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.6684 | 97.5838 | 82 | Complete curve; high efficacy | -6.175 | 2.3332 | 0.9902 | 18.8259 | 116.4097 | -1.1 | 0 0 0 0 0 0 0 0 | 15.8771 | 121.1891 | 108.6953 | 122.087 | 113.8515 | 96.8463 | 25.1626 | 23.9853 | 15.8771 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 0.0422 | 99.1812 | 82 | Complete curve; high efficacy | -7.375 | 1.3443 | 0.9933 | 10.554 | 109.7352 | -1.1 | 0 0 0 0 0 0 0 0 | 10.7613 | 114.3989 | 100.7838 | 90.7065 | 44.4742 | 11.2028 | 13.8457 | 11.3616 | 10.7613 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 0.0075 | 84.1066 | 82 | Complete curve; high efficacy | -8.125 | 4.9549 | 0.9983 | 9.4344 | 93.541 | -1.1 | 0 0 0 0 0 0 0 0 | 6.5354 | 91.7985 | 94.1104 | 12.6655 | 11.0929 | 8.6327 | 9.9971 | 10.0754 | 6.5354 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.4217 | 85.9203 | 82 | Complete curve; high efficacy | -6.375 | 0.8 | 0.9622 | 21.4982 | 107.4185 | -1.1 | 0 0 0 0 0 0 0 0 | 16.639 | 100.4185 | 107.3168 | 112.8293 | 84.5993 | 67.8817 | 38.3542 | 37.8797 | 16.639 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 0.1458 | 95.7444 | 82 | Complete curve; high efficacy | -6.8362 | 1.5579 | 0.9766 | 14.7016 | 110.446 | -1.1 | 0 0 0 0 0 0 0 | 4.7392 | 104.3625 | 115.3478 | 84.3787 | 31.7905 | 25.5998 | 18.0336 | 4.7392 | QC'd by Microsource | ||||||||||||||||||||
| Cytotoxic | 0.0036 | 107.2473 | 82 | Complete curve; high efficacy | -8.444 | 4.9549 | 0.9989 | 8.6172 | 115.8646 | -1.1 | 0 0 0 0 0 0 0 | 7.4398 | 110.6482 | 9.2236 | 10.0332 | 9.492 | 8.9141 | 6.3221 | 7.4398 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.1636 | 80.2947 | 82 | Complete curve; high efficacy | -6.7862 | 2.0479 | 0.9763 | 17.795 | 98.0898 | -1.1 | 0 0 0 0 0 0 0 | 6.7352 | 100.4625 | 95.5674 | 85.028 | 29.2532 | 27.683 | 20.0892 | 6.7352 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0231 | 97.6406 | 82 | Complete curve; high efficacy | -7.6362 | 4.9549 | 0.9995 | 10.3864 | 108.027 | -1.1 | 0 0 0 0 0 0 0 | 10.177 | 107.941 | 98.6844 | 9.8351 | 11.6961 | 11.6717 | 8.8001 | 10.177 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 1.5877 | 86.3274 | 82 | Complete curve; high efficacy | -5.7992 | 1.331 | 0.9642 | 23.21 | 109.5374 | -1.1 | 0 0 0 0 0 0 0 | 29.2744 | 118.4556 | 99.7114 | 104.7412 | 100.9923 | 85.0976 | 33.9221 | 29.2744 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 89.4885 | 82 | Complete curve; high efficacy | -7.8362 | 1.2876 | 0.9952 | 9.3441 | 98.8326 | -1.1 | 0 0 0 0 0 0 0 | 7.0005 | 90.7029 | 51.5567 | 22.536 | 11.8774 | 9.8565 | 8.188 | 7.0005 | QC'd by SynKinase | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 96.8431 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9948 | 8.9496 | 105.7927 | -1.1 | 0 0 0 0 0 0 0 | 3.839 | 102.1209 | 12.4453 | 11.4448 | 10.8821 | 9.8966 | 7.7027 | 3.839 | QC'd by Selleck |
| OUTCOME_SCREEN_HITS | OUTCOME_HEK_COUNTERSCREEN | OUTCOME_GIRK2_COUNTERSCREEN | OUTCOME_GIRK2_DOSE_RESPONSE | % Efficacy @ 25uM | % Efficacy @ 8.3uM | % Efficacy @ 2.8uM | % Efficacy @ 0.94uM | % Efficacy @ 0.15uM | % Efficacy @ 0.024uM |
|---|---|---|---|---|---|---|---|---|---|
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE | |||||||||
| INACTIVE |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0166 | 89.5276 | 84 | Complete curve; high efficacy | -7.7795 | 2.0937 | 0.9442 | 25.8586 | 115.3863 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.6755 | 108.6505 | 117.9375 | 108.1166 | 52.7453 | 48.9938 | 23.9892 | 28.8508 | 25.6865 | 29.0357 | 27.3193 | 5.6755 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.02 | 81.2231 | 83 | Complete curve; high efficacy | -7.6992 | 0.8 | 0.9723 | 16.8197 | 98.0429 | -1.1 | 0 0 0 0 0 0 0 | 8.455 | 90.2193 | 74.5452 | 44.2913 | 28.1409 | 27.059 | 21.5506 | 8.455 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0326 | 86.5937 | 83 | Complete curve; high efficacy | -7.4862 | 0.7 | 0.953 | 18.8792 | 105.4729 | -1.1 | 0 0 0 0 0 0 0 | 8.4532 | 96.8084 | 73.0667 | 45.4397 | 34.5525 | 29.7666 | 27.4306 | 8.4532 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.016 | 83.3126 | 82 | Complete curve; high efficacy | -7.7964 | 4.9549 | 0.9968 | 9.6075 | 92.9201 | -1.1 | 0 0 0 0 0 0 0 0 | 9.7773 | 89.2976 | 96.4187 | 11.9953 | 9.7167 | 8.8677 | 9.7542 | 10.3503 | 9.7773 | QC'd by LightBiologicals | |||||||||||||||||||
| Cytotoxic | 0.0106 | 94.2951 | 82 | Complete curve; high efficacy | -7.975 | 3.132 | 0.9955 | 11.6947 | 105.9898 | -1.1 | 0 0 0 0 0 0 0 0 | 11.6947 | 100.9198 | 109.3944 | 35.8242 | 11.7569 | 10.7934 | 12.3836 | 13.3145 | 11.6947 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.0027 | 88.9753 | 82 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9992 | 8.9074 | 97.8826 | -1.1 | 0 0 0 0 0 0 0 0 | 6.9034 | 97.9914 | 42.2936 | 9.9686 | 9.1038 | 8.2217 | 9.3052 | 9.0933 | 6.9034 | QC'd by Alfa Aesar | |||||||||||||||||||
| Cytotoxic | 0.0084 | 80.5139 | 82 | Complete curve; high efficacy | -8.075 | 4.9549 | 0.9973 | 8.8938 | 89.4076 | -1.1 | 0 0 0 0 0 0 0 0 | 6.3577 | 87.1572 | 91.3499 | 12.9571 | 11.0421 | 10.3402 | 8.9116 | 9.8618 | 6.3577 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.0051 | 97.542 | 82 | Complete curve; high efficacy | -8.294 | 4.5045 | 0.9992 | 8.7153 | 106.2574 | -1.1 | 0 0 0 0 0 0 0 | 7.9842 | 105.0472 | 13.7629 | 9.4904 | 9.8464 | 7.6546 | 7.149 | 7.9842 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 94.4998 | 82 | Complete curve; high efficacy | -7.6862 | 4.095 | 0.9984 | 11.2634 | 105.7632 | -1.1 | 0 0 0 0 0 0 0 | 10.8677 | 105.3873 | 87.5417 | 14.4142 | 11.9765 | 9.1461 | 9.2097 | 10.8677 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.4611 | 93.5292 | 82 | Complete curve; high efficacy | -6.3362 | 1.4641 | 0.9637 | 18.0367 | 111.5659 | -1.1 | 0 0 0 0 0 0 0 | 6.0375 | 113.1729 | 110.6758 | 104.0276 | 72.579 | 24.3332 | 35.3731 | 6.0375 | QC'd by ChemieTek | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 83.4079 | 82 | Complete curve; high efficacy | -7.5862 | 1.1705 | 0.9942 | 10.3799 | 93.7878 | -1.1 | 0 0 0 0 0 0 0 | 5.5192 | 87.4844 | 66.3422 | 28.5401 | 16.4338 | 12.1449 | 11.8707 | 5.5192 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 80.2779 | 82 | Complete curve; high efficacy | -7.6862 | 3.6772 | 0.9705 | 14.5871 | 94.865 | -1.1 | 0 0 0 0 0 0 0 | 7.2915 | 96.262 | 74.9595 | 27.5419 | 14.6063 | 13.1849 | 10.6575 | 7.2915 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 99.9965 | 82 | Complete curve; high efficacy | -7.5862 | 1.1105 | 0.9627 | 10.993 | 110.9895 | -1.1 | 0 0 0 0 0 0 0 | 3.5224 | 101.8192 | 78.6727 | 30.3442 | 20.1042 | 25.1119 | 4.4796 | 3.5224 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 90.7895 | 82 | Complete curve; high efficacy | -7.8362 | 1.3437 | 0.996 | 9.1094 | 99.8989 | -1.1 | 0 0 0 0 0 0 0 | 6.2123 | 91.4196 | 53.8318 | 19.2776 | 13.6662 | 8.5618 | 7.4372 | 6.2123 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.6513 | 81.7203 | 82 | Complete curve; high efficacy | -6.1862 | 1.4787 | 0.9896 | 21.402 | 103.1224 | -1.1 | 0 0 0 0 0 0 0 | 21.0506 | 108.9081 | 95.7413 | 101.2028 | 78.0357 | 34.6634 | 24.9893 | 21.0506 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.013 | 84.0074 | 82 | Complete curve; high efficacy | -7.8862 | 1.4163 | 0.9944 | 10.0699 | 94.0773 | -1.1 | 0 0 0 0 0 0 0 | 5.9786 | 86.0882 | 47.3557 | 17.8996 | 13.5824 | 10.5199 | 10.422 | 5.9786 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.082 | 85.0686 | 82 | Complete curve; high efficacy | -7.0862 | 0.91 | 0.9915 | 14.099 | 99.1676 | -1.1 | 0 0 0 0 0 0 0 | 10.2171 | 94.6065 | 84.9239 | 59.8081 | 27.5521 | 23.6905 | 16.7893 | 10.2171 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 84.6353 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9982 | 8.8501 | 93.4854 | -1.1 | 0 0 0 0 0 0 0 | 6.5017 | 90.3725 | 11.9975 | 10.2939 | 10.111 | 9.5279 | 8.2521 | 6.5017 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.009 | 82.7243 | 82 | Complete curve; high efficacy | -8.044 | 1.2876 | 0.9917 | 10.512 | 93.2363 | -1.1 | 0 0 0 0 0 0 0 | 7.7344 | 85.5143 | 46.4791 | 22.475 | 13.1909 | 9.7487 | 11.7333 | 7.7344 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 4.0E-4 | 94.196 | 82 | Complete curve; high efficacy | -9.375 | 2.4064 | 0.9988 | 7.7324 | 101.9284 | -1.1 | 0 0 0 0 0 0 0 | 7.3587 | 100.7694 | 74.7197 | 9.8839 | 9.6058 | 8.6476 | 8.4903 | 7.3587 | QC'd by SIGMA |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000420468 uM | Activity at 0.0001060182 uM | Activity at 0.0001893301 uM | Activity at 0.0004489405 uM | Activity at 0.0009664426 uM | Activity at 0.00171 uM | Activity at 0.00292 uM | Activity at 0.00536 uM | Activity at 0.00931 uM | Activity at 0.020 uM | Activity at 0.041 uM | Activity at 0.085 uM | Activity at 0.146 uM | Activity at 0.251 uM | Activity at 0.501 uM | Activity at 1.073 uM | Activity at 2.225 uM | Activity at 4.221 uM | Activity at 6.452 uM | Activity at 12.64 uM | Activity at 29.84 uM | Activity at 57.50 uM | Activity at 114.0 uM | Activity at 227.6 uM | Activity at 379.2 uM | Activity at 573.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -8.3336 | -1.4117 | -0.6141 | -1.8079 | 0.0446 | -8.3336 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.75 | 4.9549 | 0.364 | -29.4824 | 3.3805 | 4 | 0 0 0 0 1 | -1.3954 | 3.2535 | 0.7839 | -59.1373 | 6.0E-4 | -1.3954 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -6.75 | 3.132 | 0.7843 | 0.8702 | 12.5 | 4 | 0 0 0 0 0 | 4.4963 | 10.2975 | -0.4426 | -1.3582 | 0.1626 | 4.4963 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.0548 | -1.7066 | -2.8833 | -2.005 | 0.3693 | 2.0548 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.6422 | 0.4339 | -3.0268 | -4.4255 | -2.8516 | -5.6422 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.2315 | -0.9193 | -0.9625 | 13.7196 | -1.9704 | 0.2315 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.05 | 4.9549 | 0.5023 | -0.0525 | 7.5 | 4 | 0 0 0 0 1 | 5.313 | 2.7111 | 12.7202 | 1.5451 | -0.0438 | 5.313 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3883 | -3.3207 | -0.3808 | -0.1461 | -2.971 | 4.3883 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.7635 | -0.6995 | -1.7294 | 6.1024 | 1.8317 | 5.7635 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.3 | 1.0693 | 0.8616 | -4.2573 | 9.5 | 4 | 0 0 0 0 0 | -1.8811 | 11.1484 | 8.5502 | 5.9885 | 4.608 | -1.8811 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.7273 | -3.4115 | -0.1881 | -2.6331 | -1.6916 | -1.7273 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3895 | -3.0627 | -1.1001 | 4.7802 | 0.8642 | 4.3895 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5 | 4.9549 | 0.6649 | 10.5 | 0.7021 | 4 | 0 0 0 0 0 | 13.7837 | 4.4863 | -3.5816 | 7.2204 | 7.3678 | 13.7837 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.0179 | 3.343 | 6.8931 | 2.2936 | 4.5224 | 6.0179 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 11.3207 | 3.0878 | 5.164 | 2.5572 | 5.3615 | 11.3207 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 8.7383 | 3.2664 | 2.7307 | 3.2405 | 1.8463 | 8.7383 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.05 | 2.7202 | 0.9497 | -18.9142 | -2.2922 | 4 | 0 0 0 0 0 | -14.0952 | -1.0768 | -4.0059 | -2.4795 | -5.6228 | -14.0952 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.7765 | -2.2569 | -3.9959 | -1.3451 | 0.1566 | -7.7765 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4 | 4.9549 | 0.7054 | -25.0658 | -0.5 | 4 | 0 0 0 0 0 | -17.5549 | -2.6051 | -3.8192 | -2.6993 | 6.0774 | -17.5549 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -5.8 | 4.9549 | 0.4109 | -5.3905 | 4 | 4 | 0 0 0 0 0 | -2.4904 | 3.804 | 2.4492 | -14.0754 | 0.8551 | -2.4904 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073700 uM | Activity at 0.0000311978 uM | Activity at 0.0000755538 uM | Activity at 0.0001700784 uM | Activity at 0.0003537877 uM | Activity at 0.0007609388 uM | Activity at 0.00133 uM | Activity at 0.00267 uM | Activity at 0.00634 uM | Activity at 0.00855 uM | Activity at 0.017 uM | Activity at 0.041 uM | Activity at 0.071 uM | Activity at 0.179 uM | Activity at 0.354 uM | Activity at 0.663 uM | Activity at 1.576 uM | Activity at 1.933 uM | Activity at 5.110 uM | Activity at 9.286 uM | Activity at 17.35 uM | Activity at 44.46 uM | Activity at 93.38 uM | Activity at 162.7 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.9422 | 0 | 2.3728 | 0 | 0.4583 | 0 | 5.8022 | 9.8216 | 0 | 0 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0.7879 | 1.0771 | 0 | 0 | 4.0917 | 0 | 4.9983 | 0 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -7.3792 | 4.9549 | 0.4146 | 0.8611 | 5.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 1.8373 | 0 | 9.1117 | 5.5344 | 8.2389 | 0 | 0 | 2.3051 | 0 | 4.4881 | -0.9491 | 1.8373 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | -5.1792 | 2.7202 | 0.8215 | -20.6639 | 2.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -6.0916 | 0 | -2.7966 | 0.2285 | 8.0815 | 2.583 | 3.7354 | 7.3202 | 1.7166 | -5.5554 | -18.8865 | -6.0916 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.7495 | 7.2293 | 6.3714 | 5.6135 | 0 | 7.4829 | 0 | 1.6994 | 8.4113 | 0 | 0 | 3.7495 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.3657 | 7.1953 | 7.3079 | 0 | 0 | 1.8794 | 5.9799 | 0 | 7.4799 | 0 | 0 | 6.3657 | QC'd by BIOMOL | |||||||||||||||||||||
| Inhibitor | 14.818 | 35.5149 | 21 | Partial curve; partial efficacy | -4.8292 | 3.0654 | 0.9214 | -31.0149 | 4.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -30.4291 | 5.7772 | 8.8781 | 3.6683 | 4.227 | 4.7222 | 8.0186 | 4.5719 | -4.2187 | 3.6532 | -13.8256 | -30.4291 | QC'd by BIOMOL | ||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 5.7817 | 5.8939 | 0 | 0 | 8.5995 | 0 | 0 | 6.0744 | 0 | 6.585 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1045 | 0 | 8.2523 | 0 | -2.1724 | 7.2216 | 0 | 7.3601 | -2.8223 | -6.1446 | 4.4899 | -2.1045 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -4.4292 | 4.9549 | 0.4721 | -18.445 | 1.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -13.2875 | 0 | 7.0161 | 4.5375 | 5.0482 | 0 | 0 | 5.2422 | -2.8732 | -8.9018 | 6.1541 | -13.2875 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 9.4385 | 0 | 0 | 0 | 0.9321 | 0.5252 | 0 | 0 | 0 | 9.4894 | 0 | 9.4385 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.1894 | 0 | 6.5585 | 0 | 4.486 | 0 | 0.5381 | 0 | 4.8639 | 3.4664 | 2.4738 | -1.1894 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -6.0792 | 4.9549 | 0.4047 | 5.5 | 0.1553 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 0 | 1.472 | 4.5108 | 0 | 0 | 0 | -2.7872 | 0 | 8.3864 | 0 | 8.0615 | 0 | QC'd by BIOMOL | |||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0.7173 | 0.6679 | 2.5617 | 8.0704 | 0 | 0 | 9.8105 | 0 | 8.9731 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.1339 | -2.3294 | 0 | 8.3935 | 0 | 0 | 9.7826 | 7.5714 | 6.4163 | 0 | 0 | 1.1339 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -9.0292 | 4.9549 | 0.3898 | 2 | -12.7871 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -4.0609 | -8.9892 | 3.4212 | -1.7578 | 7.1716 | 0.6137 | 5.2177 | 6.769 | 3.1957 | -7.1191 | -0.2144 | -4.0609 | QC'd by BIOMOL | |||||||||||||||||
| Inhibitor | 20.931 | 101.634 | 41 | Partial curve; high efficacy | -4.6792 | 4.095 | 0.99 | -99.5649 | 2.069 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.6804 | 5.2511 | 0 | 7.6294 | 0 | 3.8746 | 1.2696 | 0 | 0 | 0 | -20.7764 | -91.6804 | QC'd by BIOMOL | ||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.3204 | 0 | 2.2816 | 3.412 | 1.2564 | 1.6162 | 0 | 0 | 0 | 0.2287 | 0 | QC'd by BIOMOL | |||||||||||||||||||||
| Inactive | 0 | -4.5792 | 4.5045 | 0.7778 | -24.8885 | 3.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -22.8238 | 5.7426 | 8.6462 | 6.0217 | 3.7721 | 4.1656 | 9.0629 | 3.0606 | -1.1003 | -6.0335 | 1.2279 | -22.8238 | QC'd by BIOMOL | |||||||||||||||||
| Inhibitor | 33.1734 | 109.8312 | 10 | Single point of activity | -4.4792 | 4.9549 | 0.9783 | -109.3261 | 0.505 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -91.5629 | -0.0109 | -1.0575 | 1.0949 | 2.2698 | 9.4465 | -3.4594 | 0 | -7.4354 | 0 | 0 | -91.5629 | QC'd by BIOMOL |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073700 uM | Activity at 0.0000311978 uM | Activity at 0.0000755538 uM | Activity at 0.0001700784 uM | Activity at 0.0003537877 uM | Activity at 0.0007609388 uM | Activity at 0.00133 uM | Activity at 0.00267 uM | Activity at 0.00634 uM | Activity at 0.00855 uM | Activity at 0.017 uM | Activity at 0.041 uM | Activity at 0.071 uM | Activity at 0.179 uM | Activity at 0.354 uM | Activity at 0.663 uM | Activity at 1.576 uM | Activity at 1.933 uM | Activity at 5.110 uM | Activity at 9.286 uM | Activity at 17.35 uM | Activity at 44.46 uM | Activity at 93.38 uM | Activity at 162.7 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 4.1095 | 35.9554 | 21 | Complete curve; partial efficacy | -5.3862 | 1.4787 | 0.9847 | -33.4554 | 2.5 | -1.2 | 0 0 0 0 0 0 0 | -32.4628 | 2.1833 | 5.9706 | 0 | 0 | -5.6126 | -25.295 | -32.4628 | QC'd by Axon Medchem | ||||||||||||||||||
| Inhibitor | 14.581 | 34.6571 | 10 | Partial curve; partial efficacy; poor fit | -4.8362 | 2.3332 | 0.9403 | -32.1571 | 2.5 | -2.4 | 0 0 0 0 0 0 0 | -29.7143 | 0 | 0 | 0 | 7.4115 | 5.8195 | -6.9018 | -29.7143 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.8362 | 1.8617 | 0.9256 | -16.6594 | 2.5 | 4 | 0 0 0 0 0 0 0 | -14.7161 | 2.6212 | 0.58 | 1.0251 | 6.2829 | 1.7864 | -3.3449 | -14.7161 | QC'd by Glixx | |||||||||||||||||||||
| Inhibitor | 1.636 | 66.1615 | 64 | Complete curve; partial efficacy | -5.7862 | 2.7202 | 0.9997 | -65.8116 | 0.3499 | -1.2 | 0 0 0 0 0 0 0 | -66.5014 | 0 | 0 | 0 | 0 | -37.9408 | -64.7373 | -66.5014 | QC'd by Glixx | ||||||||||||||||||
| Inactive | 0 | -4.6362 | 1.9673 | 0.7584 | -23.667 | -2.4671 | 4 | 0 0 0 0 0 0 0 | -19.3058 | -0.694 | -0.3893 | -3.2758 | -10.1148 | -2.3842 | -5.3061 | -19.3058 | QC'd by SIGMA | |||||||||||||||||||||
| Inactive | 0 | -4.7862 | 3.0654 | 1 | -20.0675 | 0 | 4 | 0 0 0 0 0 0 0 | -19.2229 | 0 | 0 | 0 | 0 | 0 | -2.9492 | -19.2229 | QC'd by Axon Medchem | |||||||||||||||||||||
| Inhibitor | 10.3225 | 47.8362 | 21 | Partial curve; partial efficacy | -4.9862 | 1.8851 | 0.9724 | -41.8362 | 6 | -2.2 | 0 0 0 0 0 0 0 | -38.781 | 9.2093 | 6.0955 | 0 | 7.7141 | 5.1385 | -14.8631 | -38.781 | QC'd by MedChem Express | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.0178 | 2.4248 | 6.4136 | 1.8969 | 0 | 6.2132 | 0 | 6.0178 | QC'd by Tocris | |||||||||||||||||||||||||
| Inhibitor | 29.0929 | 60.093 | 10 | Single point of activity | -4.5362 | 4.9549 | 1 | -60.0346 | 0.0584 | -3 | 0 0 0 0 0 0 0 | -54.4164 | 0 | 0 | 0 | 0 | 0 | 0 | -54.4164 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -6.5432 | 0 | 0 | 0 | 0 | 0 | -1.4393 | -6.5432 | QC'd by Tocris | |||||||||||||||||||||||||
| Inhibitor | 16.3601 | 36.8511 | 10 | Partial curve; partial efficacy; poor fit | -4.7862 | 1.01 | 0.8986 | -32.3511 | 4.5 | -2.4 | 0 0 0 0 0 0 0 | -23.6259 | 8.7897 | 0 | 8.6961 | 0 | 0 | -7.2303 | -23.6259 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 9.2406 | 0 | 0 | 1.7514 | 3.4967 | 0 | 7.926 | 9.2406 | QC'd by Glixx | |||||||||||||||||||||||||
| Inhibitor | 9.2 | 33.7152 | 10 | Partial curve; partial efficacy; poor fit | -5.0362 | 1.4163 | 0.9706 | -30.2152 | 3.5 | -2.4 | 0 0 0 0 0 0 0 | -27.2626 | 5.3147 | 2.6751 | 0 | 6.3042 | 0 | -12.9935 | -27.2626 | QC'd by Tocris | ||||||||||||||||||
| Inhibitor | 16.3601 | 52.6952 | 21 | Partial curve; partial efficacy | -4.7862 | 1.2876 | 0.9602 | -49.0421 | 3.653 | -2.2 | 0 0 0 0 0 0 0 | -37.7902 | 9.1493 | 0 | 0 | 5.1852 | 0 | -13.7877 | -37.7902 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.7862 | 4.4495 | 0.9565 | -27.1196 | 3 | 4 | 0 1 0 0 0 0 0 | -26.7664 | 0 | -80.8549 | 5.9752 | 5.3786 | 0 | 0.9575 | -26.7664 | QC'd by Tocris | |||||||||||||||||||||
| Inhibitor | 0.5805 | 74.8185 | 26 | Complete curve; partial efficacy | -6.2362 | 3.6772 | 0.9839 | -72.7545 | 2.064 | -1.2 | 0 0 0 0 0 0 0 | -64.7375 | 1.5093 | 2.1407 | 2.7381 | -9.5317 | -70.5587 | -81.6221 | -64.7375 | QC'd by MedChem Express | ||||||||||||||||||
| Inhibitor | 18.3564 | 99.3241 | 10 | Single point of activity | -4.7362 | 3.6272 | 0.9917 | -97.7814 | 1.5427 | -3 | 0 0 0 0 0 0 0 | -94.2017 | 0 | 8.6442 | 0 | -1.0446 | 0 | -6.3447 | -94.2017 | QC'd by Tocris | ||||||||||||||||||
| Inhibitor | 29.0929 | 85.8302 | 10 | Single point of activity | -4.5362 | 4.9549 | 0.9979 | -84.331 | 1.4991 | -3 | 0 0 0 0 0 0 0 | -76.6062 | 0.5645 | 0 | 0 | 2.1433 | 2.1495 | 3.4024 | -76.6062 | QC'd by MedChem Express | ||||||||||||||||||
| Inhibitor | 12.9953 | 49.1721 | 21 | Partial curve; partial efficacy | -4.8862 | 2.2526 | 0.9678 | -45.6725 | 3.4996 | -2.2 | 0 0 0 0 0 0 0 | -42.1761 | 7.8315 | 0.285 | 0 | 1.2696 | 6.3138 | -12.2728 | -42.1761 | QC'd by Tocris | ||||||||||||||||||
| Inactive | 0 | -4.6862 | 1.8851 | 0.8683 | -38.0965 | -12.0167 | 4 | 0 0 0 0 0 0 0 | -33.4065 | -7.5139 | -13.5025 | -14.684 | -16.035 | -8.8732 | -16.7676 | -33.4065 | QC'd by Selleck |
| Standard Type | PubChem Standard Value | Ki | Target Accession(s) | Ligand | Target |
|---|---|---|---|---|---|
| Ki | 27.1 | 27100 | P00547 | BDBM85123 | Homoserine kinase |
| Ki | 0.46 | 460 | P00547 | BDBM85124 | Homoserine kinase |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00111 uM | Activity at 0.00284 uM | Activity at 0.00446 uM | Activity at 0.00891 uM | Activity at 0.015 uM | Activity at 0.029 uM | Activity at 0.036 uM | Activity at 0.073 uM | Activity at 0.113 uM | Activity at 0.149 uM | Activity at 0.293 uM | Activity at 0.487 uM | Activity at 0.726 uM | Activity at 1.458 uM | Activity at 2.011 uM | Activity at 3.331 uM | Activity at 5.199 uM | Activity at 7.343 uM | Activity at 13.78 uM | Activity at 20.90 uM | Activity at 36.53 uM | Activity at 60.71 uM | Activity at 87.88 uM | Activity at 127.3 uM | Activity at 194.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 1.3987 | 0.9996 | -13.0836 | -0.5853 | 4 | 0 0 0 1 | -0.8016 | -2.9877 | -9.467 | -12.5697 | -0.8016 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inhibitor | 12.5893 | 40.5111 | 10 | Single point of activity | -4.9 | 4.5045 | 0.9991 | -45.3562 | -4.8451 | -3 | 0 0 0 0 | -45.0493 | -5.3378 | -3.9936 | -8.2693 | -45.0493 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | -2.0352 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | -0.9941 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 1 | 0 | -13.6335 | 4 | 0 0 0 0 | 0 | -12.1946 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -13.3369 | -12.1444 | -5.0835 | -13.8274 | -13.3369 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | -4.5112 | -3.9568 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | 0 | 0 | 0 | 0 | 0 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.8079 | 0.9998 | -19.413 | 1.5 | 4 | 0 0 0 1 | -2.2992 | 0 | -11.3763 | -18.6775 | -2.2992 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7721 | 4 | -15.6398 | 4 | 0 0 0 0 | 0 | -10.469 | -15.9421 | -20.9499 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9987 | -20.1455 | -0.5 | 4 | 0 0 0 0 | -19.2879 | 0 | -0.8113 | -0.6866 | -19.2879 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.9999 | -7.3207 | 0 | 4 | 0 0 0 0 | -6.934 | 0 | 0 | 0 | -6.934 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -10.1341 | 0 | -23.8022 | -3.1543 | -10.1341 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.8265 | 0.9999 | -31.5926 | 1 | 4 | 0 0 0 1 | -8.4479 | 0 | -12.323 | -29.2439 | -8.4479 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.7 | 0.9542 | 2 | -18.0981 | 4 | 0 0 0 0 | 0 | -15.9151 | -9.0083 | -6.2439 | 0 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7994 | 0.5884 | -8.2 | 4 | 0 0 0 0 | -1.1763 | -9.1365 | -5.7126 | -9.75 | -1.1763 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 0.6 | 0.9653 | -16.2314 | 0.756 | 4 | 0 0 0 0 | -14.3595 | -3.5367 | -8.6422 | -10.5182 | -14.3595 | QC'd by "Asinex Ltd." | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -3.3063 | -1.5829 | -0.4572 | 0 | -3.3063 | QC'd by "Asinex Ltd." | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.7973 | -6.6878 | -1.5 | 4 | 0 0 0 1 | 0 | -2.5435 | 0 | -5.5731 | 0 | QC'd by "Asinex Ltd." |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 1.33 | IC50 | = | 1330 | nM | Dtt Insensitive |
| 0.39 | IC50 | = | 390 | nM | Dtt Insensitive |
| 1.6 | IC50 | = | 1600 | nM | Dtt Insensitive |
| 0.14 | IC50 | = | 140 | nM | Dtt Insensitive |
| 2.8 | IC50 | = | 2800 | nM | Dtt Insensitive |
| 0.39 | IC50 | = | 390 | nM | Dtt Insensitive |
| 1.58 | IC50 | = | 1580 | nM | Dtt Insensitive |
| 0.03 | IC50 | = | 30 | nM | Dtt Insensitive |
| 3.99 | IC50 | = | 3990 | nM | Dtt Insensitive |
| 0.36 | IC50 | = | 360 | nM | Dtt Insensitive |
| 0.22 | IC50 | = | 220 | nM | Dtt Insensitive |
| 1.37 | IC50 | = | 1370 | nM | Dtt Insensitive |
| 0.22 | IC50 | = | 220 | nM | Dtt Insensitive |
| 0.4 | IC50 | = | 400 | nM | Dtt Insensitive |
| 4.58 | IC50 | = | 4580 | nM | Dtt Insensitive |
| 4.38 | IC50 | = | 4380 | nM | Dtt Insensitive |
| 0.19 | IC50 | = | 190 | nM | Dtt Insensitive |
| 1.74 | IC50 | = | 1740 | nM | Dtt Insensitive |
| 3.86 | IC50 | = | 3860 | nM | Dtt Insensitive |
| 0.05 | IC50 | = | 50 | nM | Dtt Insensitive |
| Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Inhibition | > | 60 | % |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 13.77 | % | |
| Inhibition | = | 2.35 | % | |
| Inhibition | = | 21.17 | % | |
| Inhibition | = | 18.36 | % | |
| Inhibition | = | 5.381 | % | |
| Inhibition | = | 18.17 | % | |
| Inhibition | = | 10.15 | % | |
| Inhibition | = | 29.56 | % | |
| Inhibition | = | 18.27 | % | |
| Inhibition | = | 11.42 | % | |
| Inhibition | = | 15.4 | % | |
| Inhibition | = | 7.437 | % | |
| Inhibition | = | -3.216 | % | |
| Inhibition | = | 18 | % | |
| Inhibition | = | 1.021 | % | |
| Inhibition | = | 16.4 | % | |
| Inhibition | = | 2.544 | % | |
| Inhibition | = | 19.11 | % | |
| Inhibition | = | 26.15 | % | |
| Inhibition | = | 5.133 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00111 uM | Activity at 0.00284 uM | Activity at 0.00446 uM | Activity at 0.00891 uM | Activity at 0.015 uM | Activity at 0.029 uM | Activity at 0.036 uM | Activity at 0.073 uM | Activity at 0.113 uM | Activity at 0.149 uM | Activity at 0.293 uM | Activity at 0.487 uM | Activity at 0.726 uM | Activity at 1.458 uM | Activity at 2.011 uM | Activity at 3.331 uM | Activity at 5.199 uM | Activity at 7.343 uM | Activity at 13.78 uM | Activity at 20.90 uM | Activity at 36.52 uM | Activity at 60.71 uM | Activity at 87.88 uM | Activity at 127.3 uM | Activity at 194.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 1.4641 | 0.71 | -12.454 | -2 | 4 | 0 0 0 0 | -11.2117 | -5.2093 | 0.6206 | -7.2594 | -11.2117 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -11.3429 | -16.0267 | -12.2608 | -14.6132 | -11.3429 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 1.6259 | 0.9272 | -14.3148 | -0.877 | 4 | 0 0 0 0 | -15.2623 | -7.8142 | -13.6096 | -13.0621 | -15.2623 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -12.3142 | -9.814 | -12.586 | -8.4662 | -12.3142 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4 | -8.2677 | -9.1999 | -12.2836 | -11.2753 | -8.2677 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.5045 | 0.9238 | -23.3577 | -9.0057 | 4 | 0 0 0 0 | -23.2147 | -6.6714 | -11.5717 | -9.7492 | -23.2147 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inhibitor | 11.2202 | 18.8957 | 21 | Partial curve; partial efficacy | -4.95 | 3.5117 | 0.9065 | -31.7758 | -12.8801 | -2.2 | 0 0 0 0 | -31.4798 | -16.0985 | -9.0667 | -16.5103 | -31.4798 | QC'd by "Chem Div" | ||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8003 | -13.5254 | -8.8783 | 4 | 0 0 0 0 | -13.3545 | -10.4528 | -7.3986 | -12.9731 | -13.3545 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 2.3332 | 0.9015 | -5.5393 | 8 | 4 | 0 0 0 0 | -5.4494 | 5.4818 | 10.3071 | 0 | -5.4494 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.9673 | 0.9741 | -21.6735 | -12.4937 | 4 | 0 0 0 0 | -21.3946 | -13.4008 | -12.078 | -16.6303 | -21.3946 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4 | -5.6419 | -17.3934 | -2.7552 | -14.5706 | -5.6419 | QC'd by "Chem Div" | |||||||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8944 | -16.0102 | -8.6848 | 4 | 0 0 0 0 | -15.0085 | -7.2373 | -9.9603 | -8.6791 | -15.0085 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.5579 | 0.9997 | -19.5854 | -2.0513 | 4 | 0 0 0 1 | -5.8527 | -2.9594 | -9.4187 | -17.9878 | -5.8527 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.9974 | 18 | -20.2383 | 4 | 0 0 0 0 | 12.7737 | -17.6986 | -10.2115 | 1.1055 | 12.7737 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 1.8851 | 0.9998 | -14.291 | -6.7783 | 4 | 0 0 0 1 | -6.726 | -6.8986 | -8.4505 | -13.1591 | -6.726 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 0.9 | 0.9901 | -24.8053 | -6.5569 | 4 | 0 0 0 0 | -19.0044 | -6.7141 | -9.2211 | -12.2131 | -19.0044 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inhibitor | 10 | 25.7525 | 21 | Partial curve; partial efficacy | -5 | 4.9549 | 0.9958 | -34.5683 | -8.8157 | -2.2 | 0 0 0 0 | -34.709 | -9.7184 | -7.7631 | -13.3604 | -34.709 | QC'd by "Chem Div" | ||||||||||||||||||||||
| Inactive | 0 | 0.5 | 0.7446 | -13.2445 | -2.1109 | 4 | 0 0 0 0 | -9.3704 | -2.5924 | -6.2168 | -4.8236 | -9.3704 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Inactive | 0 | 4.9549 | 0.8017 | -7.4285 | -18.0168 | 4 | 0 0 0 0 | -7.4434 | -13.764 | -5.7738 | -9.5578 | -7.4434 | QC'd by "Chem Div" | ||||||||||||||||||||||||||
| Activator | 31.6228 | 49 | 0 | Partial curve; high efficacy | -4.5 | 0.8 | 0.9998 | 65 | 114 | 2.1 | 0 0 0 1 | 118.3965 | 112.9568 | 110.0983 | 102.4909 | 118.3965 | QC'd by "Chem Div" |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Inhibition | = | 17 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 47 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 0 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 8 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 47 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 10 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 16 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 14 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 34 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 9 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 5 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 24 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 3 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 0 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 0 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 0 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 19 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 48 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 0 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| Inhibition | = | 26 | % | % Inhibition At 10Um Mers 3Cl-Pro |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 26.8 | IC50 | = | 26800 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| 10 | IC50 | > | 10000 | nM | Ic50 Mers 3Cl-Pro |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0001943322 uM | Activity at 0.0004169086 uM | Activity at 0.0006184621 uM | Activity at 0.00125 uM | Activity at 0.00187 uM | Activity at 0.00374 uM | Activity at 0.00620 uM | Activity at 0.011 uM | Activity at 0.019 uM | Activity at 0.034 uM | Activity at 0.057 uM | Activity at 0.103 uM | Activity at 0.171 uM | Activity at 0.309 uM | Activity at 0.513 uM | Activity at 0.958 uM | Activity at 1.860 uM | Activity at 2.874 uM | Activity at 5.579 uM | Activity at 8.623 uM | Activity at 16.74 uM | Activity at 25.51 uM | Activity at 50.00 uM | Activity at 83.33 uM | Activity at 250.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -3.9794 | -0.1198 | -7.062 | -11.5818 | -9.1944 | -3.8178 | -1.1441 | -5.6132 | -4.9511 | -5.5587 | -6.1624 | -3.9794 | QC'd by ACC | ||||||||||||||||||||||
| Inactive | 0 | -8.1979 | 0.3 | 0.6089 | 9 | 31 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 10.1722 | 23.9242 | 24.6558 | 19.165 | 21.6603 | 12.6253 | 18.7614 | 7.4709 | 19.8924 | 13.7815 | 8.1899 | 10.1722 | QC'd by Pharmaron | ||||||||||||||||||
| Activator | 8.9552 | 43.219 | 0 | Partial curve; partial efficacy; poor fit | -5.0479 | 1.331 | 0.9247 | 36.0289 | -7.1901 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 29.4662 | -7.0776 | -6.47 | -9.2528 | -8.4641 | -9.2431 | -10.5751 | -5.2276 | 3.4595 | -2.8811 | 13.3578 | 29.4662 | QC'd by SIGMA | |||||||||||||||
| Inactive | 0 | -5.2479 | 0.4 | 0.3288 | -23.185 | -14.6129 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -20.7246 | -17.2155 | -15.3616 | -10.5108 | -18.084 | -14.0374 | -14.4678 | -15.7745 | -20.1988 | -20.9875 | -15.4123 | -20.7246 | QC'd by SIGMA | ||||||||||||||||||
| Activator | 7.1133 | 61.8654 | 0 | Partial curve; partial efficacy | -5.1479 | 1.2221 | 0.9859 | 57.5474 | -4.318 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 47.1053 | -2.7798 | -7.765 | -4.3513 | -5.9053 | -6.287 | 0.5579 | -3.1459 | 0.6085 | 10.4777 | 28.7029 | 47.1053 | QC'd by Microsource | |||||||||||||||
| Inactive | 0 | -4.9979 | 0.6 | 0.6273 | 32 | 8 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 26.1083 | 11.8412 | 9.2893 | 3.7334 | 5.7073 | 7.1178 | 15.2025 | 8.2193 | 19.3164 | 10.3908 | 17.5927 | 26.1083 | QC'd by Sequoia | ||||||||||||||||||
| Inactive | 0 | -5.7479 | 2.8473 | 0.9367 | -8.4579 | 12.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -9.1316 | 17.4896 | 14.595 | 13.7121 | 12.1503 | 11.9632 | 10.0103 | 8.3538 | 10.3971 | -3.7628 | -7.349 | -9.1316 | QC'd by SIGMA | ||||||||||||||||||
| Inactive | 0 | -6.1979 | 0.6 | 0.5448 | 12 | -8.0775 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -5.6385 | -0.4717 | -21.3146 | -4.9131 | -1.5492 | -3.8745 | -4.9958 | -1.2489 | 4.1826 | 6.3826 | 8.2921 | -5.6385 | QC'd by Sytravon | ||||||||||||||||||
| Activator | 0.2832 | 102.7435 | 0 | Partial curve; high efficacy | -6.5479 | 1.7885 | 0.9885 | 108.7435 | 6 | 2.1 | 0 0 0 0 0 0 0 0 1 1 1 | -95.9146 | 9.0336 | 7.0268 | 8.0091 | 2.4957 | 15.7387 | 21.8311 | 60.2571 | 100.6884 | -22.8645 | -96.4497 | -95.9146 | QC'd by Sytravon | |||||||||||||||
| Inactive | 0 | -7.2479 | 0.5 | 0.7058 | 16 | 2 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 7.4072 | 1.8128 | 5.5963 | 8.7635 | 0.2931 | 10.4118 | 8.754 | 14.2725 | 11.8513 | 14.5589 | 14.8196 | 7.4072 | QC'd by Sytravon | ||||||||||||||||||
| Inactive | 0 | -6.0979 | 2.3332 | 0.5919 | -23.922 | -17.4242 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -24.9757 | -19.9067 | -14.6333 | -19.3926 | -16.8611 | -18.3099 | -13.2702 | -19.0908 | -20.4306 | -26.6017 | -20.1209 | -24.9757 | QC'd by Selleck | ||||||||||||||||||
| Activator | 2.5239 | 37.0529 | 0 | Partial curve; partial efficacy | -5.5979 | 1.1 | 0.8899 | 26 | -11.0529 | 2.2 | 0 0 0 0 0 0 0 0 0 0 1 | -9.5741 | -14.2107 | -9.4787 | -6.7894 | -9.9383 | -13.1553 | -12.9138 | -4.8051 | 1.4732 | 2.2794 | 22.5785 | -9.5741 | QC'd by MedChem Express | |||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -13.8524 | -9.282 | -5.697 | -4.2734 | -5.2179 | -3.3835 | -12.0959 | -4.8479 | 2.5228 | -14.939 | -6.0319 | -13.8524 | QC'd by Analyticon | ||||||||||||||||||||||
| Inactive | 0 | -5.6592 | 1.7137 | 0.8905 | -25.7583 | -14.3423 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -25.6319 | -16.1698 | -13.0793 | -14.8397 | -14.8495 | -13.9732 | -15.8115 | -12.3686 | -13.1319 | -19.083 | -21.7489 | -25.6319 | QC'd by Analyticon | ||||||||||||||||||
| Inactive | 0 | -7.5092 | 4.9549 | 0.6197 | 22.5 | 13 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 9.5983 | 19.8083 | 9.922 | 13.4662 | 14.1998 | 12.2364 | 23.0077 | 19.3858 | 26.1903 | 24.5969 | 18.4377 | 9.5983 | QC'd by Analyticon | ||||||||||||||||||
| Inactive | 0 | -7.8479 | 1.8265 | 0.8442 | -13.182 | -2.5342 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -17.235 | -1.6952 | -2.6747 | -4.1488 | -5.954 | -12.7639 | -12.1446 | -11.8915 | -10.8594 | -10.5634 | -16.1912 | -17.235 | QC'd by Analyticon | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -17.7491 | -20.0995 | -21.9281 | -15.9595 | -15.8056 | -19.8756 | -17.2058 | -20.6448 | -14.277 | -20.5571 | -18.9876 | -17.7491 | QC'd by MedChem Express | ||||||||||||||||||||||
| Inactive | 0 | -6.4479 | 0.4 | 0.9032 | 38 | 18.5 | 4 | 0 0 0 0 0 0 0 0 1 1 1 | 1.0469 | 19.2218 | 19.9617 | 23.3104 | 22.2636 | 24.4161 | 23.6531 | 28.4144 | 30.5796 | 20.1972 | 11.5512 | 1.0469 | QC'd by MedChem Express | ||||||||||||||||||
| Inactive | 0 | -5.2592 | 2.4729 | 0.682 | -17.8276 | 16.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -13.8151 | 21.038 | 12.3878 | 2.6823 | 12.392 | 17.0966 | 20.5651 | 19.3395 | 28.6792 | 15.007 | 4.7718 | -13.8151 | QC'd by Analyticon | ||||||||||||||||||
| Inactive | 0 | -5.3479 | 1.1 | 0.676 | -42.4703 | -22.0276 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -37.2303 | -24.1889 | -23.1958 | -17.9964 | -27.2599 | -16.273 | -18.493 | -30.4886 | -23.3633 | -27.5267 | -38.9926 | -37.2303 | QC'd by Tocris |
| Standard Type | Standard Relation | Standard Value | Standard Text Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| Inhibition | = | -13.63 | % | Outside typical range | |
| Inhibition | = | -37.85 | % | Outside typical range | |
| Inhibition | = | -31.68 | % | Outside typical range | |
| Inhibition | = | -40.84 | % | Outside typical range | |
| Inhibition | = | -33.51 | % | Outside typical range | |
| Inhibition | = | -11.71 | % | Outside typical range | |
| Inhibition | = | -12.48 | % | Outside typical range | |
| Inhibition | = | 8.75 | % | ||
| Inhibition | = | -57.22 | % | Outside typical range | |
| Inhibition | = | -43.91 | % | Outside typical range | |
| Inhibition | = | -42.06 | % | Outside typical range | |
| Inhibition | = | 25.26 | % | ||
| Inhibition | = | 31.78 | % | ||
| Inhibition | = | -63.83 | % | Outside typical range | |
| Inhibition | = | 1.14 | % | ||
| Inhibition | = | -17.63 | % | Outside typical range | |
| Inhibition | = | 14.49 | % | ||
| Inhibition | = | 3.28 | % | ||
| Inhibition | = | 10.08 | % | ||
| Inhibition | = | 13.93 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008338173 uM | Activity at 0.00124 uM | Activity at 0.00249 uM | Activity at 0.00373 uM | Activity at 0.00749 uM | Activity at 0.012 uM | Activity at 0.023 uM | Activity at 0.038 uM | Activity at 0.069 uM | Activity at 0.114 uM | Activity at 0.206 uM | Activity at 0.342 uM | Activity at 0.619 uM | Activity at 1.026 uM | Activity at 1.916 uM | Activity at 3.719 uM | Activity at 5.749 uM | Activity at 11.16 uM | Activity at 17.25 uM | Activity at 33.47 uM | Activity at 51.01 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 2.5901 | 109.9607 | 86 | Complete curve; high efficacy | -5.5867 | 1.21 | 0.9897 | -108.9607 | 1 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -111.4117 | 1.5556 | 0.1686 | 0.5912 | -2.3208 | 0.5546 | -1.7222 | -9.4735 | -49.3194 | -78.617 | -90.0782 | -111.4117 | QC'd by Tocris | |||||||||||||||
| Inhibitor | 2.0574 | 90.6453 | 86 | Complete curve; high efficacy | -5.6867 | 1 | 0.9996 | -95.4556 | -4.8103 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.4326 | -5.6107 | -5.4875 | -5.5173 | -5.2586 | -8.3832 | -11.5147 | -25.8607 | -48.4417 | -70.9035 | -84.9963 | -91.4326 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 2.5901 | 98.496 | 86 | Complete curve; high efficacy | -5.5867 | 4.095 | 0.9994 | -101.9353 | -3.4393 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -102.3447 | -3.0022 | -2.6536 | -4.2124 | -2.3934 | -2.0327 | -2.9719 | -4.1726 | -25.8834 | -97.2501 | -101.4914 | -102.3447 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 2.5901 | 105.4137 | 85 | Complete curve; high efficacy | -5.5867 | 0.8 | 0.9976 | -100.4137 | 5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.9545 | 7.5354 | 4.4635 | 3.5886 | 3.2188 | -2.4359 | -10.3973 | -17.5405 | -39.749 | -63.8592 | -82.3674 | -90.9545 | QC'd by Tocris | |||||||||||||||
| Inhibitor | 12.981 | 85.5335 | 82 | Complete curve; high efficacy | -4.8867 | 4.9549 | 0.9967 | -87.5434 | -2.0099 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -85.325 | -1.8297 | -3.5602 | -3.91 | -1.0422 | -1.2527 | -1.4075 | -3.9675 | -0.4249 | -0.4411 | -70.6158 | -85.325 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 4.105 | 93.3436 | 44 | Partial curve; partial efficacy | -5.3867 | 0.7 | 0.9979 | -89.8436 | 3.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -77.6537 | 4.6033 | 2.5741 | 1.5557 | 0.6086 | -2.727 | -5.8785 | -14.7051 | -32.247 | -48.4602 | -62.0742 | -77.6537 | QC'd by APAC | |||||||||||||||
| Inhibitor | 9.1899 | 81.7124 | 42 | Partial curve; partial efficacy | -5.0367 | 1.1 | 0.9987 | -84.3066 | -2.5942 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.9596 | -2.0933 | -3.4233 | -3.1998 | -2.8829 | -2.6472 | -1.7452 | -7.9092 | -14.2316 | -31.7647 | -56.8608 | -72.9596 | QC'd by Glixx | |||||||||||||||
| Inhibitor | 18.3362 | 72.9849 | 41 | Partial curve; partial efficacy | -4.7367 | 2.0479 | 0.956 | -75.9849 | -3 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -70.3563 | -1.7343 | -12.6104 | -4.171 | 4.0314 | 0.7429 | -2.4048 | -1.3619 | -5.566 | -12.2596 | -31.5981 | -70.3563 | QC'd by Princeton | |||||||||||||||
| Inhibitor | 18.3362 | 73.4507 | 41 | Partial curve; partial efficacy | -4.7367 | 1.5386 | 0.9946 | -82.1193 | -8.6686 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.0345 | -7.7697 | -8.6785 | -9.0916 | -9.479 | -8.3494 | -7.2238 | -9.8284 | -10.1223 | -21.6905 | -41.8484 | -72.0345 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 23.0839 | 88.6587 | 41 | Partial curve; high efficacy | -4.6367 | 2.4064 | 0.9832 | -92.503 | -3.8444 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.6892 | -3.5026 | -2.9812 | -3.2189 | -4.6998 | -1.9536 | -5.3552 | -5.0547 | -4.555 | -8.1241 | -29.8904 | -90.6892 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 2.9061 | 55.2291 | 23 | Complete curve; partial efficacy | -5.5367 | 0.7 | 0.9915 | -52.2291 | 3 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -45.2494 | 2.5384 | 2.2282 | 2.6616 | 0.2019 | -1.9921 | -2.393 | -10.3912 | -22.8963 | -27.6273 | -41.5174 | -45.2494 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 16.3421 | 81.363 | 21 | Partial curve; partial efficacy | -4.7867 | 1.2876 | 0.9793 | -77.863 | 3.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -64.8858 | 4.6206 | 6.6103 | 6.3475 | 5.4319 | 1.9795 | -3.9421 | 1.1208 | -2.7854 | -12.2731 | -33.9047 | -64.8858 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 18.3362 | 58.5289 | 21 | Partial curve; partial efficacy | -4.7367 | 1.2221 | 0.9689 | -56.0289 | 2.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -46.6908 | 4.2396 | 3.6058 | 6.5955 | 3.8076 | 1.7487 | -1.2158 | -0.5062 | -1.333 | -10.3615 | -20.7839 | -46.6908 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 18.3362 | 63.6574 | 21 | Partial curve; partial efficacy | -4.7367 | 1.1 | 0.931 | -61.1574 | 2.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -50.9645 | 6.8226 | 3.1352 | 3.2109 | 3.824 | 2.1658 | -3.0387 | 1.5869 | -9.9978 | -10.7579 | -20.2792 | -50.9645 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 16.0176 | 53.6802 | 21 | Partial curve; partial efficacy | -4.7954 | 1.1 | 0.9332 | -59.7413 | -6.061 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -47.4137 | -9.9147 | -8.0265 | -4.9002 | -7.74 | -1.7175 | -9.128 | -10.8321 | -13.0781 | -14.6739 | -24.7757 | -47.4137 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 11.2739 | 38.613 | 21 | Partial curve; partial efficacy | -4.9479 | 1.331 | 0.9367 | -43.2673 | -4.6543 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -36.0561 | -3.0892 | -0.9619 | -5.6766 | -4.829 | -2.5548 | -6.7305 | -9.0092 | -6.7736 | -9.551 | -16.7432 | -36.0561 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 14.5649 | 67.4959 | 21 | Partial curve; partial efficacy | -4.8367 | 1.1 | 0.983 | -68.9959 | -1.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -54.1635 | 0.8818 | -0.2331 | -1.5067 | 0.5982 | -1.1965 | -4.6761 | -8.0636 | -7.7637 | -15.5972 | -40.2452 | -54.1635 | QC'd by Glixx | |||||||||||||||
| Inhibitor | 16.3421 | 64.0334 | 21 | Partial curve; partial efficacy | -4.7867 | 1.2475 | 0.987 | -60.0334 | 4 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -50.0278 | 6.6044 | 3.8507 | 2.6676 | 3.539 | 3.919 | 1.7621 | 3.4514 | 1.0614 | -12.3878 | -25.4689 | -50.0278 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 18.3362 | 70.4556 | 21 | Partial curve; partial efficacy | -4.7367 | 1.6259 | 0.9803 | -68.9556 | 1.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -60.4873 | 5.8295 | 1.293 | 2.1703 | 4.2411 | 0.8209 | -1.4934 | 1.094 | -2.4894 | -11.3309 | -27.749 | -60.4873 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 18.3362 | 52.9268 | 21 | Partial curve; partial efficacy | -4.7367 | 1.4163 | 0.9896 | -55.8043 | -2.8775 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -46.5035 | -5.734 | -1.7587 | -1.7696 | -3.3881 | -1.8874 | -1.1479 | -3.8743 | -3.938 | -12.2677 | -26.0707 | -46.5035 | QC'd by Scientific Exchange |
| Standard Type | Standard Relation | Standard Value | Standard Text Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|---|
| Inhibition | = | -7.39 | % | ||
| Inhibition | = | -3.08 | % | ||
| Inhibition | = | 97.8 | % | ||
| Inhibition | = | -9.09 | % | ||
| Inhibition | = | 47.05 | % | ||
| Inhibition | = | -5.94 | % | ||
| Inhibition | = | -0.48 | % | ||
| Inhibition | = | -2.98 | % | ||
| Inhibition | = | 1.42 | % | ||
| Inhibition | = | 12.25 | % | ||
| Inhibition | = | -2.13 | % | ||
| Inhibition | = | -4.43 | % | ||
| Inhibition | = | 4.53 | % | ||
| Inhibition | = | -5.82 | % | ||
| Inhibition | = | 10.36 | % | ||
| Inhibition | = | -1.3 | % | ||
| Inhibition | = | 12.9 | % | ||
| Inhibition | = | -3.37 | % | ||
| Inhibition | = | 3.17 | % | ||
| Inhibition | = | -0.97 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008333407 uM | Activity at 0.00124 uM | Activity at 0.00249 uM | Activity at 0.00373 uM | Activity at 0.00748 uM | Activity at 0.012 uM | Activity at 0.023 uM | Activity at 0.038 uM | Activity at 0.069 uM | Activity at 0.115 uM | Activity at 0.206 uM | Activity at 0.344 uM | Activity at 0.619 uM | Activity at 1.033 uM | Activity at 1.912 uM | Activity at 3.719 uM | Activity at 5.737 uM | Activity at 11.16 uM | Activity at 17.21 uM | Activity at 33.48 uM | Activity at 50.94 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.259 | 92.1053 | 90 | Complete curve; high efficacy | -6.5867 | 3.99 | 0.9964 | -92.1053 | 0 | -1.1 | 0 0 0 0 0 0 0 0 0 1 1 | 0 | 0 | 0 | 0 | 0 | 0 | -26.9057 | -94.1772 | -91.9507 | -86.4857 | -67.7124 | 0 | QC'd by GVK | |||||||||||||||
| Inhibitor | 0.2057 | 96.8464 | 90 | Complete curve; high efficacy | -6.6867 | 0.5 | 0.9869 | -93.8464 | 3 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -88.3676 | 1.1189 | -13.0457 | -11.9936 | -16.2335 | -34.002 | -49.7919 | -58.5074 | -65.2049 | -76.2052 | -87.4254 | -88.3676 | QC'd by Cayman | |||||||||||||||
| Inhibitor | 0.819 | 98.0804 | 88 | Complete curve; high efficacy | -6.0867 | 4.9549 | 0.9998 | -98.0804 | 0 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.0711 | 0 | 0 | 0 | 0 | 0 | -1.3807 | -18.4263 | -95.594 | -97.8277 | -98.7603 | -99.0711 | QC'd by SigmaAldrich | |||||||||||||||
| Inhibitor | 1.8336 | 90.2671 | 86 | Complete curve; high efficacy | -5.7367 | 1 | 0.9788 | -90.7671 | -0.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.0467 | -11.9779 | 1.8615 | -1.1149 | 0.3145 | 0.4826 | -1.9658 | -28.8777 | -45.643 | -65.5697 | -80.455 | -90.0467 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 1.6342 | 97.7298 | 86 | Complete curve; high efficacy | -5.7867 | 1.111 | 0.9949 | -91.7298 | 6 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.5467 | 4.7471 | 6.691 | 5.7493 | 4.6126 | 4.6496 | -4.2191 | -15.4016 | -52.1541 | -67.1067 | -83.4886 | -91.5467 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 1.6342 | 80.4432 | 85 | Complete curve; high efficacy | -5.7867 | 1.4163 | 0.9844 | -82.9432 | -2.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.9426 | 0.0017 | -2.7057 | -0.9635 | 0.2371 | -10.9118 | -7.4073 | -13.1382 | -51.7572 | -66.8444 | -76.6984 | -86.9426 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 11.5693 | 142.2969 | 83 | Complete curve; high efficacy | -4.9367 | 4.9549 | 0.9843 | -146.2969 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -145.1358 | -11.1377 | -4.9584 | -14.1999 | -14.9851 | -11.5225 | 0 | 0 | 0 | 0 | -127.65 | -145.1358 | QC'd by BOC Sciences | |||||||||||||||
| Inhibitor | 2.9828 | 82.3803 | 83 | Complete curve; high efficacy | -5.5254 | 1.111 | 0.9956 | -67.3803 | 15 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -66.4085 | 15.7312 | 16.4085 | 16.6901 | 13.7564 | 9.8487 | 6.846 | 0.9994 | -27.4034 | -46.3695 | -59.0006 | -66.4085 | QC'd by ChemRoutes | |||||||||||||||
| Inhibitor | 5.1678 | 82.6705 | 83 | Complete curve; high efficacy | -5.2867 | 1.6924 | 0.9917 | -84.1705 | -1.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -84.0024 | 2.3399 | 0.0403 | -2.9808 | -0.1304 | -2.852 | -3.4511 | -8.3788 | -9.4642 | -47.6561 | -71.3126 | -84.0024 | QC'd by ChemRoutes | |||||||||||||||
| Inhibitor | 0.5798 | 74.5177 | 67 | Complete curve; partial efficacy | -6.2367 | 1.7885 | 0.9905 | -84.7108 | -10.1932 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -85.7922 | -6.411 | -13.187 | -13.2655 | -8.1855 | -13.3519 | -15.8017 | -54.0083 | -71.981 | -81.2068 | -87.6924 | -85.7922 | QC'd by Pharmaron | |||||||||||||||
| Inhibitor | 4.105 | 72.32 | 64 | Complete curve; partial efficacy | -5.3867 | 1.5095 | 0.9933 | -89.4126 | -17.0927 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -90.3158 | -20.231 | -13.4106 | -18.193 | -17.5607 | -16.7098 | -16.5249 | -21.8958 | -32.2241 | -62.637 | -77.852 | -90.3158 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 10.3112 | 71.1255 | 62 | Complete curve; partial efficacy | -4.9867 | 2.4064 | 0.9806 | -86.3626 | -15.2371 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -85.1702 | -13.7671 | -12.9532 | -14.248 | -25.2859 | -13.461 | -15.2839 | -12.6976 | -15.193 | -27.0044 | -68.8421 | -85.1702 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 9.1899 | 67.0328 | 62 | Complete curve; partial efficacy | -5.0367 | 1.8265 | 0.9939 | -76.8664 | -9.8336 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -70.7322 | -10.7907 | -8.6988 | -8.6114 | -9.0149 | -11.4364 | -9.2773 | -12.7817 | -14.9845 | -27.5022 | -61.3355 | -70.7322 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 8.1905 | 106.3573 | 43 | Partial curve; high efficacy | -5.0867 | 0.5 | 0.9661 | -114.4951 | -8.1378 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.7387 | -3.4482 | -13.2288 | -17.8624 | -15.8022 | -16.7275 | -16.6046 | -30.643 | -44.1175 | -47.0452 | -75.7003 | -86.7387 | QC'd by BIOMOL | |||||||||||||||
| Inhibitor | 11.5693 | 128.7048 | 43 | Partial curve; high efficacy | -4.9367 | 3.2975 | 0.9933 | -121.2048 | 7.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -121.6916 | -2.9913 | 7.4474 | 9.6012 | 7.7378 | 8.8039 | 9.9566 | 10.4974 | 8.9646 | -2.3207 | -89.0932 | -121.6916 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 12.981 | 67.2156 | 42 | Partial curve; partial efficacy | -4.8867 | 1.1 | 0.9972 | -84.7948 | -17.5792 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.5718 | -16.8006 | -15.8993 | -18.304 | -17.8466 | -17.1874 | -19.286 | -19.9586 | -25.6491 | -34.807 | -56.3917 | -72.5718 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 16.3421 | 132.3132 | 42 | Partial curve; high efficacy | -4.7867 | 1.2876 | 0.9936 | -133.8132 | -1.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -111.511 | -1.0773 | -3.2771 | 0.1916 | 1.699 | -3.4092 | -5.8988 | -5.8666 | -5.6959 | -30.4121 | -64.6714 | -111.511 | QC'd by Life Chemicals | |||||||||||||||
| Inhibitor | 20.5735 | 98.5677 | 41 | Partial curve; high efficacy | -4.6867 | 3.0654 | 0.9967 | -98.5677 | 0 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.635 | 1.3662 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -36.802 | -96.635 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 23.0839 | 122.5543 | 41 | Partial curve; high efficacy | -4.6367 | 4.095 | 0.8771 | -108.8172 | 13.7371 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -101.695 | -5.9208 | 5.5438 | 3.1644 | 7.2743 | 6.3627 | 13.6092 | 23.7295 | 37.4283 | 32.861 | -14.4157 | -101.695 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 0.6506 | 55.9366 | 25 | Complete curve; partial efficacy | -6.1867 | 2.7202 | 0.9428 | -55.4366 | 0.5 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -56.768 | 0 | 0 | 0 | 0 | 0 | 0 | -22.2431 | -60.7149 | -64.5173 | -39.0284 | -56.768 | QC'd by Microsource |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008233323 uM | Activity at 0.00124 uM | Activity at 0.00246 uM | Activity at 0.00377 uM | Activity at 0.00739 uM | Activity at 0.013 uM | Activity at 0.023 uM | Activity at 0.039 uM | Activity at 0.069 uM | Activity at 0.117 uM | Activity at 0.206 uM | Activity at 0.351 uM | Activity at 0.618 uM | Activity at 1.053 uM | Activity at 1.927 uM | Activity at 3.720 uM | Activity at 5.782 uM | Activity at 11.16 uM | Activity at 17.34 uM | Activity at 33.48 uM | Activity at 50.65 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.0311 | 106.0932 | 88 | Complete curve; high efficacy | -5.9867 | 1 | 0.99 | -101.5932 | 4.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.443 | 9.6981 | 0.0044 | 10.7127 | -6.9536 | -2.2974 | -11.3519 | -36.1756 | -62.6061 | -84.2015 | -97.0708 | -98.443 | QC'd by SigmaAldrich | |||||||||||||||
| Inhibitor | 0.919 | 111.4174 | 88 | Complete curve; high efficacy | -6.0367 | 1.1 | 0.9849 | -97.9174 | 13.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.3646 | 7.4049 | 18.9193 | 7.1763 | 21.7697 | -0.2744 | 2.4876 | -34.3663 | -61.0045 | -84.521 | -92.9929 | -96.3646 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 1.4565 | 108.773 | 87 | Complete curve; high efficacy | -5.8367 | 0.9 | 0.9912 | -101.273 | 7.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.1328 | 10.0785 | 5.0453 | -2.2102 | 12.6454 | -0.7438 | -8.1305 | -26.4248 | -53.3465 | -74.5675 | -90.2675 | -98.1328 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 1.2981 | 107.8235 | 87 | Complete curve; high efficacy | -5.8867 | 1 | 0.9927 | -101.3235 | 6.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.0532 | 1.4822 | 7.4843 | 11.2258 | 4.259 | -2.139 | -4.1769 | -31.5222 | -52.5312 | -85.691 | -92.9687 | -97.0532 | QC'd by Tocris | |||||||||||||||
| Inhibitor | 1.1569 | 92.804 | 87 | Complete curve; high efficacy | -5.9367 | 1.21 | 0.976 | -96.804 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.0357 | 7.5254 | -14.9467 | -7.974 | -2.01 | -12.1318 | -6.5988 | -36.504 | -61.4538 | -83.187 | -95.332 | -96.0357 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 1.4565 | 95.0665 | 87 | Complete curve; high efficacy | -5.8367 | 1 | 0.9926 | -99.0665 | -4 | -1.1 | 0 0 0 1 0 0 0 0 0 0 0 | -95.9947 | 2.226 | -3.6974 | -10.3519 | 30.2584 | -11.8423 | -14.0904 | -31.1299 | -59.4844 | -78.33 | -91.9831 | -95.9947 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 1.8336 | 110.3651 | 86 | Complete curve; high efficacy | -5.7367 | 1.2475 | 0.9945 | -99.3651 | 11 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.9958 | 15.7976 | 10.2462 | 6.9507 | 9.7919 | 10.487 | 7.1488 | -16.8798 | -40.2744 | -77.7593 | -95.7275 | -94.9958 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 2.0574 | 107.491 | 86 | Complete curve; high efficacy | -5.6867 | 1.2221 | 0.9783 | -93.491 | 14 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -92.2341 | 13.6326 | 2.3539 | 16.6843 | 13.8078 | 18.0626 | 18.6688 | -16.6338 | -34.2006 | -66.3978 | -87.0605 | -92.2341 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 2.0574 | 110.0333 | 86 | Complete curve; high efficacy | -5.6867 | 0.9 | 0.9865 | -101.5333 | 8.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.5375 | 2.575 | 14.8435 | 2.5813 | 14.7298 | 0.6931 | -8.9626 | -15.325 | -43.8815 | -68.5449 | -89.3213 | -94.5375 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 1.4193 | 104.5919 | 86 | Complete curve; high efficacy | -5.8479 | 1.2221 | 0.9804 | -95.5919 | 9 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.5631 | 3.3382 | 12.118 | 3.4571 | 9.6852 | 16.6298 | 7.975 | -15.319 | -22.3855 | -65.6932 | -86.2038 | -91.5631 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 2.9061 | 93.5741 | 85 | Complete curve; high efficacy | -5.5367 | 1.1 | 0.9812 | -95.0741 | -1.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -87.5452 | -10.254 | -2.4392 | -6.9481 | -0.2163 | 5.7988 | -1.9135 | -16.6748 | -36.4819 | -65.1695 | -80.976 | -87.5452 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 3.2607 | 99.0329 | 85 | Complete curve; high efficacy | -5.4867 | 1.3443 | 0.9632 | -93.5329 | 5.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.6989 | -3.2822 | -3.8569 | 16.5612 | 4.9904 | 9.2073 | 14.3935 | -14.7708 | -21.951 | -60.88 | -83.1689 | -91.6989 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 4.105 | 87.5642 | 84 | Complete curve; high efficacy | -5.3867 | 1.3443 | 0.9761 | -91.5642 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.7085 | -6.111 | -5.8563 | -10.9621 | -8.2001 | 8.6265 | -8.333 | -8.9422 | -26.9277 | -56.1051 | -82.3696 | -86.7085 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 4.105 | 94.7579 | 84 | Complete curve; high efficacy | -5.3867 | 2.5334 | 0.9206 | -89.7579 | 5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.487 | -2.0682 | -6.8818 | 18.9719 | 9.0794 | 26.6747 | -3.0833 | -13.5252 | -0.671 | -59.3912 | -82.4679 | -94.487 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 5.1678 | 111.3093 | 84 | Complete curve; high efficacy | -5.2867 | 1.111 | 0.972 | -99.8093 | 11.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.1233 | 18.4667 | 0.4547 | 21.059 | 2.256 | 16.8043 | 10.3614 | -3.5838 | -12.6269 | -47.0769 | -77.3938 | -90.1233 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 4.7274 | 110.2377 | 84 | Complete curve; high efficacy | -5.3254 | 0.9 | 0.9989 | -105.2377 | 5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.324 | 4.4649 | 2.4173 | 4.8498 | 4.6961 | 3.5345 | -3.5636 | -16.4321 | -36.8529 | -65.4142 | -85.8945 | -95.324 | QC'd by ChemRoutes | |||||||||||||||
| Inhibitor | 6.6764 | 102.7154 | 83 | Complete curve; high efficacy | -5.1755 | 1 | 0.9925 | -85.7154 | 17 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -78.2745 | 24.4006 | 14.9714 | 11.3833 | 13.8008 | 14.6635 | 12.9746 | 2.3962 | -20.6265 | -48.4262 | -68.5588 | -78.2745 | QC'd by SigmaAldrich | |||||||||||||||
| Inhibitor | 6.5059 | 96.4115 | 83 | Complete curve; high efficacy | -5.1867 | 1.9887 | 0.985 | -81.9115 | 14.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -82.3535 | 8.7981 | 14.3495 | 7.7738 | 19.7333 | 20.1479 | 16.828 | 11.7491 | 12.1698 | -29.6807 | -65.7541 | -82.3535 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 9.1899 | 94.2615 | 83 | Complete curve; high efficacy | -5.0367 | 4.9549 | 0.984 | -98.2615 | -4 | -1.1 | 0 0 1 0 0 0 0 0 0 0 0 | -96.3348 | 3.9892 | -13.5099 | 51.244 | -3.2532 | -4.0654 | 1.2359 | -5.945 | -8.4138 | -9.4606 | -95.1238 | -96.3348 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 7.2998 | 94.5572 | 83 | Complete curve; high efficacy | -5.1367 | 1.6604 | 0.9244 | -98.5572 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.7665 | 13.2607 | -14.9584 | 6.5402 | -15.1959 | -12.7095 | -5.0389 | -9.5867 | -19.5062 | -34.0351 | -85.2014 | -91.7665 | QC'd by Cayman |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008286089 uM | Activity at 0.00124 uM | Activity at 0.00248 uM | Activity at 0.00373 uM | Activity at 0.00744 uM | Activity at 0.013 uM | Activity at 0.023 uM | Activity at 0.040 uM | Activity at 0.069 uM | Activity at 0.111 uM | Activity at 0.206 uM | Activity at 0.353 uM | Activity at 0.624 uM | Activity at 1.115 uM | Activity at 1.930 uM | Activity at 3.480 uM | Activity at 5.807 uM | Activity at 11.67 uM | Activity at 17.60 uM | Activity at 33.48 uM | Activity at 51.06 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.4125 | 97.0225 | 87 | Complete curve; high efficacy | -5.85 | 0.9 | 0.957 | -104.5706 | -7.5482 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.2822 | -11.2901 | -18.8772 | -11.6693 | -43.4765 | -44.248 | -44.8652 | -79.0266 | -84.1272 | -97.3439 | -97.9126 | -97.2822 | QC'd by GVK | |||||||||||||||
| Inhibitor | 1.4565 | 126.3464 | 87 | Complete curve; high efficacy | -5.8367 | 1.6924 | 0.9931 | -110.8464 | 15.5 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -107.4093 | 37.8717 | 13.6822 | 13.0642 | 13.7769 | 20.3364 | 16.8573 | -14.9483 | -55.8355 | -105.909 | -107.0903 | -107.4093 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 0.4606 | 100.4149 | 87 | Complete curve; high efficacy | -6.3367 | 4.9549 | 0.928 | -79.2963 | 21.1186 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -80.6952 | 5.9836 | 3.8993 | 20.8057 | 13.0962 | 32.3231 | 52.0621 | -68.7904 | -68.3183 | -79.5773 | -81.684 | -80.6952 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 2.0574 | 127.043 | 87 | Complete curve; high efficacy | -5.6867 | 1.4641 | 0.9422 | -115.043 | 12 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -108.2966 | 27.2748 | 27.2349 | 5.9265 | 1.1464 | -4.6804 | -0.5882 | -17.3408 | -29.4928 | -107.7134 | -107.9427 | -108.2966 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 2.5901 | 129.4537 | 86 | Complete curve; high efficacy | -5.5867 | 1.8265 | 0.9531 | -115.9537 | 13.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -106.891 | 25.296 | 17.7047 | -2.1682 | 23.671 | 14.5545 | -10.4673 | 19.514 | -32.1645 | -97.9389 | -107.1103 | -106.891 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 2.5901 | 97.8696 | 86 | Complete curve; high efficacy | -5.5867 | 4.5045 | 0.9733 | -101.8696 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -102.3291 | -9.4766 | -13.236 | -4.3824 | -14.7087 | -2.6339 | 12.4352 | 1.8642 | -20.9241 | -97.3951 | -102.8986 | -102.3291 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 2.0574 | 116.3481 | 86 | Complete curve; high efficacy | -5.6867 | 2.2526 | 0.9818 | -104.8481 | 11.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.9889 | 17.8764 | 5.4145 | 18.6017 | 21.3823 | 1.3125 | 6.6781 | -1.5616 | -36.6071 | -101.7374 | -101.5594 | -99.9889 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 4.6058 | 118.7769 | 85 | Complete curve; high efficacy | -5.3367 | 3.99 | 0.9688 | -109.2769 | 9.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -107.3196 | 27.4991 | 9.9838 | -0.7377 | 0.5034 | -4.1022 | 11.1252 | 17.5502 | 11.1202 | -74.9358 | -107.3595 | -107.3196 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 5.6234 | 109.1639 | 84 | Complete curve; high efficacy | -5.25 | 1.8851 | 0.9652 | -105.1639 | 4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.784 | 11.6252 | 4.7127 | 3.4254 | -4.5143 | -4.9331 | -20.5877 | -16.0337 | -50.9533 | -98.0537 | -98.468 | -96.784 | QC'd by DC Chemicals | |||||||||||||||
| Inhibitor | 7.2998 | 107.4957 | 84 | Complete curve; high efficacy | -5.1367 | 1.2221 | 0.9783 | -111.4957 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -103.2367 | -13.2538 | -0.0267 | 2.0065 | -5.8194 | 3.6661 | -9.6857 | -15.95 | -22.7304 | -46.7644 | -84.8842 | -103.2367 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 11.5693 | 97.5368 | 82 | Complete curve; high efficacy | -4.9367 | 4.9549 | 0.9485 | -101.0368 | -3.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.6418 | -12.4352 | 3.0387 | -14.6153 | -12.2261 | 4.3512 | 2.4381 | 8.8048 | -13.7254 | 1.3125 | -89.3911 | -99.6418 | QC'd by Chembridge | |||||||||||||||
| Inhibitor | 11.5693 | 98.828 | 82 | Complete curve; high efficacy | -4.9367 | 4.5045 | 0.9121 | -102.828 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -102.6227 | -1.8731 | -15.5763 | -26.5166 | -12.5464 | -17.5339 | -1.8642 | -10.0727 | 9.9126 | -6.6647 | -86.3836 | -102.6227 | QC'd by Vitas | |||||||||||||||
| Inhibitor | 23.0839 | 79.4758 | 41 | Partial curve; partial efficacy | -4.6367 | 4.095 | 0.8235 | -82.9758 | -3.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -77.0049 | -11.7145 | -10.8602 | -14.6242 | 6.0908 | 18.6951 | -3.1322 | -12.0125 | -9.7079 | 6.7448 | -19.7584 | -77.0049 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 20.5735 | 99.8048 | 41 | Partial curve; high efficacy | -4.6867 | 1.7137 | 0.8734 | -98.3048 | 1.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.2323 | 0.8676 | -9.5389 | -7.519 | 1.0411 | 15.2114 | 11.4787 | 16.8843 | -15.6741 | -12.7422 | -33.4839 | -86.2323 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 20.5735 | 83.1863 | 41 | Partial curve; partial efficacy | -4.6867 | 2.7202 | 0.8668 | -73.6863 | 9.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -73.3388 | 22.1298 | 2.3847 | -10.3842 | 10.4999 | 0.1023 | 19.6605 | 20.9241 | 9.8814 | 6.9673 | -17.4182 | -73.3388 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 18.3362 | 121.8345 | 41 | Partial curve; high efficacy | -4.7367 | 2.7868 | 0.9485 | -108.3345 | 13.5 | -2.1 | 1 0 0 0 0 0 0 0 0 0 0 | -101.2702 | -23.8516 | -2.0733 | 30.6275 | 8.1196 | 14.117 | 5.0987 | 17.9209 | 20.4391 | 7.8615 | -40.4645 | -101.2702 | QC'd by Chembridge | |||||||||||||||
| Inhibitor | 20.5735 | 84.413 | 41 | Partial curve; partial efficacy | -4.6867 | 2.3332 | 0.892 | -78.413 | 6 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.8494 | -2.8207 | 2.4603 | 17.2135 | 14.9356 | 1.8464 | 12.4664 | -6.6959 | 15.6163 | -7.5679 | -24.6257 | -72.8494 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 20.5735 | 92.8259 | 41 | Partial curve; high efficacy | -4.6867 | 4.095 | 0.9171 | -78.3259 | 14.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -73.2263 | 10.5264 | -3.151 | 15.1049 | 18.8505 | 15.9912 | 27.2547 | 8.3797 | 13.9514 | 23.9589 | -13.1452 | -73.2263 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 20.5735 | 83.1871 | 41 | Partial curve; high efficacy | -4.6867 | 3.132 | 0.8423 | -62.1278 | 21.0593 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -64.6929 | -2.5364 | 22.2932 | 14.2676 | 18.2804 | 20.73 | 37.9927 | 16.4544 | 38.6652 | 23.812 | -8.8563 | -64.6929 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 0.5798 | 33.9105 | 23 | Complete curve; partial efficacy | -6.2367 | 4.4495 | 0.9281 | -32.9105 | 1 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -32.7721 | -6.1106 | -3.9992 | 6.126 | -3.0206 | 1.9187 | 10.2023 | -19.0021 | -31.9399 | -32.7413 | -33.1189 | -32.7721 | QC'd by Cayman |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008338173 uM | Activity at 0.00124 uM | Activity at 0.00249 uM | Activity at 0.00373 uM | Activity at 0.00749 uM | Activity at 0.012 uM | Activity at 0.023 uM | Activity at 0.038 uM | Activity at 0.069 uM | Activity at 0.114 uM | Activity at 0.206 uM | Activity at 0.342 uM | Activity at 0.619 uM | Activity at 1.026 uM | Activity at 1.916 uM | Activity at 3.719 uM | Activity at 5.749 uM | Activity at 11.16 uM | Activity at 17.25 uM | Activity at 33.47 uM | Activity at 51.01 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.819 | 87.0385 | 87 | Complete curve; high efficacy | -6.0867 | 1.3443 | 0.9961 | -84.5385 | 2.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -87.5139 | 1.114 | 0 | 0 | 2.9793 | 4.2662 | -7.9466 | -33.2435 | -61.766 | -76.6432 | -81.3334 | -87.5139 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 1.6342 | 89.6613 | 86 | Complete curve; high efficacy | -5.7867 | 0.8 | 0.9918 | -94.197 | -4.5357 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.227 | -2.5297 | -3.4679 | -9.635 | -7.1695 | -14.792 | -15.9048 | -29.4095 | -56.4408 | -69.3217 | -79.2648 | -90.227 | QC'd by APAC | |||||||||||||||
| Inhibitor | 1.8336 | 94.4961 | 86 | Complete curve; high efficacy | -5.7367 | 1.8617 | 0.9989 | -94.9961 | -0.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.3776 | -1.3502 | -0.2066 | -2.4258 | 2.7774 | -1.6197 | -2.0908 | -11.2497 | -47.9814 | -82.942 | -94.0736 | -95.3776 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 1.8336 | 98.7589 | 86 | Complete curve; high efficacy | -5.7367 | 1.8079 | 0.9926 | -96.2589 | 2.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.1761 | 2.1633 | -3.0162 | -1.7391 | 3.8376 | 6.8892 | 3.9784 | -5.961 | -50.1564 | -79.4444 | -97.2312 | -96.1761 | QC'd by Chembridge | |||||||||||||||
| Inhibitor | 1.8336 | 117.5517 | 86 | Complete curve; high efficacy | -5.7367 | 1.111 | 0.9917 | -104.0517 | 13.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.2038 | 16.027 | 12.5284 | 20.7396 | 10.9928 | 3.4056 | 0.7171 | -11.6101 | -40.2962 | -81.8609 | -95.3712 | -99.2038 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 4.105 | 102.2033 | 85 | Complete curve; high efficacy | -5.3867 | 2.7868 | 0.9963 | -102.2033 | 0 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -100.6552 | 0 | 0 | 0.4466 | 2.6196 | 1.3014 | -7.0848 | -0.1399 | -9.5349 | -70.1791 | -102.6138 | -100.6552 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 3.1774 | 96.7129 | 85 | Complete curve; high efficacy | -5.4979 | 1.6266 | 0.9968 | -95.7129 | 1 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -88.6231 | 0 | 0.7243 | 0 | 1.1631 | 0 | 0 | -0.2194 | -6.346 | -40.8346 | -79.8345 | -88.6231 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 6.5059 | 128.0887 | 85 | Complete curve; high efficacy | -5.1867 | 1.5386 | 0.9928 | -132.0887 | -4 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -129.4987 | 0.1476 | -4.8849 | -6.6137 | -8.5236 | -3.9326 | -10.9532 | -8.9047 | -15.3414 | -65.574 | -105.6081 | -129.4987 | QC'd by Axon Medchem | |||||||||||||||
| Inhibitor | 2.9061 | 93.6968 | 85 | Complete curve; high efficacy | -5.5367 | 1.8265 | 0.9956 | -91.6968 | 2 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -89.3731 | 0 | 4.5946 | 0 | 4.2711 | 0 | 0 | 0.8493 | -27.8387 | -73.8967 | -86.3827 | -89.3731 | QC'd by Cayman | |||||||||||||||
| Inhibitor | 3.2607 | 111.2988 | 85 | Complete curve; high efficacy | -5.4867 | 2.0479 | 0.9948 | -99.2988 | 12 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.5907 | 15.5592 | 13.8366 | 17.0294 | 10.5999 | 11.5463 | 7.6551 | 2.3867 | -12.0459 | -71.5767 | -97.3518 | -96.5907 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 3.6585 | 92.9769 | 84 | Complete curve; high efficacy | -5.4367 | 1.6924 | 0.9965 | -92.4769 | 0.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.6636 | 0 | 0 | 0 | 0 | 0 | 3.988 | -8.3142 | -20.7831 | -59.875 | -87.9355 | -90.6636 | QC'd by SigmaAldrich | |||||||||||||||
| Inhibitor | 5.7984 | 95.9744 | 84 | Complete curve; high efficacy | -5.2367 | 2.3332 | 0.9922 | -96.9744 | -1 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -93.0365 | -0.6867 | 0.4248 | 0 | 1.8559 | -0.4094 | -1.8277 | -5.021 | -11.0122 | -41.926 | -95.6355 | -93.0365 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 4.6058 | 102.1196 | 84 | Complete curve; high efficacy | -5.3367 | 3.9295 | 0.9779 | -94.6196 | 7.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -85.5338 | -0.6404 | 1.6432 | 2.6726 | 6.2083 | 10.2808 | 16.1174 | 12.5897 | 7.6496 | -60.847 | -103.7496 | -85.5338 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 4.6058 | 107.4581 | 84 | Complete curve; high efficacy | -5.3367 | 1.4781 | 0.992 | -98.9581 | 8.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -93.1809 | 8.8312 | 9.0882 | 4.1985 | 8.5795 | 6.838 | 10.2878 | 8.55 | -19.9304 | -49.1765 | -88.9783 | -93.1809 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 5.7984 | 98.6956 | 84 | Complete curve; high efficacy | -5.2367 | 1.111 | 0.9913 | -96.6956 | 2 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.0332 | 0.4441 | 3.1214 | 6.0644 | 3.2241 | -5.0004 | 0 | -5.7269 | -22.3838 | -41.1315 | -74.3311 | -90.0332 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 6.5059 | 101.6649 | 84 | Complete curve; high efficacy | -5.1867 | 1.2876 | 0.9986 | -106.4121 | -4.7472 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.6368 | -3.7525 | -4.5439 | -5.9657 | -1.8727 | -5.3345 | -7.423 | -10.2197 | -20.0785 | -51.0609 | -82.5103 | -99.6368 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 5.0359 | 90.6477 | 84 | Complete curve; high efficacy | -5.2979 | 3.6272 | 0.9923 | -92.6477 | -2 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -92.4628 | 2.3975 | 4.229 | -3.4667 | -5.4432 | -3.7131 | -3.586 | 0.2734 | -4.8695 | -11.6501 | -80.2351 | -92.4628 | QC'd by Prestwick | |||||||||||||||
| Inhibitor | 5.7984 | 107.7915 | 84 | Complete curve; high efficacy | -5.2367 | 1.9282 | 0.99 | -98.7915 | 9 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.1748 | 10.4673 | -0.855 | 7.5419 | 10.1304 | 13.4601 | 14.9602 | 6.5091 | -1.1759 | -44.2917 | -87.5379 | -95.1748 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 4.7166 | 102.0548 | 84 | Complete curve; high efficacy | -5.3264 | 1.8617 | 0.9952 | -99.5548 | 2.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.6028 | 3.9695 | -2.5222 | -0.8884 | 4.8727 | 7.4236 | 2.1813 | -0.4619 | -13.1259 | -55.3921 | -92.8344 | -97.6028 | QC'd by Vitas | |||||||||||||||
| Inhibitor | 5.1678 | 114.217 | 84 | Complete curve; high efficacy | -5.2867 | 1.5579 | 0.995 | -99.717 | 14.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.5698 | 16.455 | 20.1531 | 14.5778 | 12.3859 | 15.0224 | 9.8723 | 5.3386 | -3.7884 | -44.983 | -85.8105 | -94.5698 | QC'd by Chemdiv |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000080000 uM | Activity at 0.0000294000 uM | Activity at 0.0000322389 uM | Activity at 0.0000640000 uM | Activity at 0.0001602685 uM | Activity at 0.0003305803 uM | Activity at 0.0007029698 uM | Activity at 0.00145 uM | Activity at 0.00305 uM | Activity at 0.00484 uM | Activity at 0.00883 uM | Activity at 0.016 uM | Activity at 0.036 uM | Activity at 0.076 uM | Activity at 0.127 uM | Activity at 0.227 uM | Activity at 0.400 uM | Activity at 1.089 uM | Activity at 1.958 uM | Activity at 4.491 uM | Activity at 9.517 uM | Activity at 15.29 uM | Activity at 27.66 uM | Activity at 48.83 uM | Activity at 98.28 uM | Activity at 150.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.1535 | 84.011 | 86 | Complete curve; high efficacy | -5.938 | 2.9523 | 0.9935 | -85.511 | -1.5 | -1.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0.5517 | 0 | -10.1942 | -66.3862 | -86.3747 | 0 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 4.0381 | 107.1309 | 85 | Complete curve; high efficacy | -5.3938 | 1.1 | 0.9833 | -107.6309 | -0.5 | -1.1 | 0 0 0 0 0 0 0 | -99.1076 | 3.0643 | -3.3561 | 2.7295 | -17.6643 | -28.702 | -81.8703 | -99.1076 | QC'd by Prestwick | ||||||||||||||||||||
| Inhibitor | 4.5309 | 100.6619 | 85 | Complete curve; high efficacy | -5.3438 | 1.4641 | 0.9928 | -111.2365 | -10.5746 | -1.1 | 0 0 0 0 0 0 0 | -102.4277 | -6.7289 | -14.1368 | -11.7774 | -11.5064 | -34.358 | -88.9997 | -102.4277 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 3.2076 | 94.9956 | 85 | Complete curve; high efficacy | -5.4938 | 1.6924 | 0.997 | -110.0264 | -15.0308 | -1.1 | 0 0 0 0 0 0 0 | -108.5073 | -10.859 | -15.7072 | -17.8113 | -19.7979 | -44.1871 | -99.3353 | -108.5073 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 3.2076 | 94.3335 | 85 | Complete curve; high efficacy | -5.4938 | 1.5579 | 0.9917 | -98.6297 | -4.2962 | -1.1 | 0 0 0 0 0 0 0 | -97.268 | -10.9671 | -0.2469 | -8.8219 | -8.6028 | -35.074 | -85.0291 | -97.268 | QC'd by Vitas | ||||||||||||||||||||
| Inhibitor | 4.0381 | 101.2244 | 85 | Complete curve; high efficacy | -5.3938 | 2.2481 | 0.9999 | -101.2244 | 0 | -1.1 | 0 0 0 0 0 0 0 | -101.0224 | 0 | 0 | 0.6663 | -1.57 | -17.0563 | -89.6716 | -101.0224 | QC'd by DC Chemicals | ||||||||||||||||||||
| Inhibitor | 4.5309 | 102.5293 | 84 | Complete curve; high efficacy | -5.3438 | 1.8851 | 0.9958 | -104.0293 | -1.5 | -1.1 | 0 0 0 0 0 0 0 | -100.8035 | 0 | 0 | -6.9667 | 0.0183 | -19.6985 | -87.3271 | -100.8035 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 5.1525 | 90.1537 | 84 | Complete curve; high efficacy | -5.288 | 1.9673 | 0.9895 | -98.5024 | -8.3487 | -1.1 | 0 0 0 0 0 0 0 | -96.571 | -12.4368 | -8.9031 | -14.8602 | -3.6239 | -19.2852 | -77.5914 | -96.571 | QC'd by EMD Chemicals | ||||||||||||||||||||
| Inhibitor | 6.4 | 96.4761 | 83 | Complete curve; high efficacy | -5.1938 | 3.9295 | 0.9988 | -94.9761 | 1.5 | -1.1 | 0 0 0 0 0 0 0 | -95.3575 | 0 | 3.3535 | 0 | 0 | 2.0026 | -79.8012 | -95.3575 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 6.4 | 89.099 | 83 | Complete curve; high efficacy | -5.1938 | 4.4495 | 0.9997 | -88.599 | 0.5 | -1.1 | 0 0 0 0 0 0 0 | -88.4222 | 0 | 0.504 | 2.2243 | 0 | 0 | -77.8921 | -88.4222 | QC'd by SigmaAldrich | ||||||||||||||||||||
| Inhibitor | 4.0928 | 572.5887 | 65 | Partial curve; high efficacy | -5.388 | 2.9023 | 1 | -572.5887 | 0 | -2.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0 | 0 | 0 | -52.3008 | -521.4833 | 0 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 2.5479 | 77.6423 | 65 | Complete curve; partial efficacy | -5.5938 | 4.5045 | 0.9919 | -92.3162 | -14.6738 | -1.2 | 0 0 0 0 0 0 0 | -90.5524 | -12.7147 | -12.5699 | -11.8115 | -21.2763 | -34.6101 | -93.8172 | -90.5524 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 2.0239 | 79.2033 | 65 | Complete curve; partial efficacy | -5.6938 | 1.111 | 0.9975 | -92.0986 | -12.8952 | -1.2 | 0 0 0 0 0 0 0 | -89.2428 | -13.3008 | -14.4831 | -11.996 | -25.7417 | -51.5286 | -82.1843 | -89.2428 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 2.5479 | 39.7531 | 64 | Complete curve; partial efficacy | -5.5938 | 4.5045 | 0.9617 | -72.8813 | -33.1282 | -1.2 | 0 0 0 0 0 0 0 | -68.5285 | -37.2443 | -35.4912 | -31.4131 | -28.8568 | -43.7703 | -77.3346 | -68.5285 | QC'd by Microsource | ||||||||||||||||||||
| Inhibitor | 5.7812 | 259.63 | 50 | Partial curve; high efficacy | -5.238 | 1.6924 | 0.9999 | -259.63 | 0 | -2.1 | 0 0 0 0 0 0 0 | -250.1252 | 0 | 0 | 0 | -1.0316 | -34.0768 | -179.1962 | -250.1252 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 4.0928 | 222.4626 | 50 | Partial curve; high efficacy | -5.388 | 2.5884 | 0.9995 | -221.4626 | 1 | -2.1 | 0 0 0 0 0 0 1 | 0 | 0 | 0 | 0 | 3.8047 | -24.8352 | -196.3321 | 0 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 18.0377 | 742.5376 | 49 | Partial curve; high efficacy | -4.7438 | 2.7202 | 1 | -741.5376 | 1 | -2.1 | 0 0 0 0 0 0 0 | -698.2464 | 0 | 0 | 3.8335 | 0 | 0 | -124.2034 | -698.2464 | QC'd by Vitas | ||||||||||||||||||||
| Inhibitor | 16.0761 | 622.5036 | 49 | Partial curve; high efficacy | -4.7938 | 2.2526 | 1 | -622.5036 | 0 | -2.1 | 0 0 0 0 0 0 0 | -576.3922 | 0 | 0 | 0 | 0 | -5.8017 | -157.3588 | -576.3922 | QC'd by Glixx | ||||||||||||||||||||
| Inhibitor | 16.0761 | 415.8307 | 46 | Partial curve; high efficacy | -4.7938 | 2.2526 | 0.9995 | -418.3307 | -2.5 | -2.1 | 0 0 0 0 0 0 0 | -387.3433 | -6.0045 | 0 | 0 | -3.7575 | -3.0222 | -113.565 | -387.3433 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 16.2936 | 426.1901 | 46 | Partial curve; high efficacy | -4.788 | 2.7202 | 0.9998 | -425.6901 | 0.5 | -2.1 | 0 0 0 0 0 0 0 | -400.8381 | 0 | 0 | 0 | 0 | 3.5739 | -74.4409 | -400.8381 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0003886644 uM | Activity at 0.0008234935 uM | Activity at 0.00124 uM | Activity at 0.00246 uM | Activity at 0.00377 uM | Activity at 0.00739 uM | Activity at 0.013 uM | Activity at 0.023 uM | Activity at 0.039 uM | Activity at 0.069 uM | Activity at 0.117 uM | Activity at 0.206 uM | Activity at 0.352 uM | Activity at 0.618 uM | Activity at 1.055 uM | Activity at 1.924 uM | Activity at 3.720 uM | Activity at 5.772 uM | Activity at 11.16 uM | Activity at 17.32 uM | Activity at 33.48 uM | Activity at 50.62 uM | Activity at 100.00 uM | Activity at 166.7 uM | Activity at 500.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 2.0574 | 123.2685 | 87 | Complete curve; high efficacy | -5.6867 | 2.4064 | 0.9964 | -118.2685 | 5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -115.0908 | 2.888 | 5.4004 | 6.5859 | 4.0413 | 2.8079 | 3.3793 | 2.2835 | -43.9445 | -114.475 | -115.9495 | -115.0908 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 2.0574 | 120.4506 | 87 | Complete curve; high efficacy | -5.6867 | 2.3332 | 0.9968 | -118.4506 | 2 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -116.8152 | 4.9144 | -0.2165 | 1.3423 | 3.4165 | 1.011 | -2.1306 | -5.6378 | -45.6943 | -113.1005 | -116.7151 | -116.8152 | QC'd by Bio Vision | |||||||||||||||
| Inhibitor | 4.105 | 101.9386 | 84 | Complete curve; high efficacy | -5.3867 | 2.8473 | 0.9578 | -98.4386 | 3.5 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -116.3577 | 4.7063 | 4.8851 | 4.1444 | 3.4294 | 1.8409 | -0.4526 | 0.3312 | -2.0485 | -70.9205 | -76.0559 | -116.3577 | QC'd by Adooq | |||||||||||||||
| Inhibitor | 7.2998 | 92.0717 | 83 | Complete curve; high efficacy | -5.1367 | 1.8851 | 0.982 | -90.0717 | 2 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -80.9075 | 1.9866 | -0.0034 | 1.859 | 2.4519 | 2.6136 | 4.709 | -0.0577 | -7.01 | -25.1697 | -83.0089 | -80.9075 | QC'd by APAC | |||||||||||||||
| Inhibitor | 9.1899 | 126.488 | 83 | Complete curve; high efficacy | -5.0367 | 4.9549 | 0.9935 | -123.488 | 3 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -120.3587 | 4.6848 | 12.6958 | 0.5587 | 0.4971 | 0.534 | 1.4389 | 0.9107 | -0.7262 | -3.4411 | -118.5135 | -120.3587 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 7.9813 | 140.9485 | 44 | Partial curve; high efficacy | -5.0979 | 1.111 | 0.9968 | -139.4485 | 1.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -110.6734 | 6.1272 | 1.2202 | 1.473 | 0.7797 | -1.9022 | 0.5033 | -2.5401 | -12.7365 | -32.4047 | -69.1492 | -110.6734 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 11.5693 | 133.5906 | 43 | Partial curve; high efficacy | -4.9367 | 1.3443 | 0.998 | -128.5906 | 5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -112.7988 | 6.1326 | 4.0479 | 4.4981 | 3.3555 | 3.7443 | 4.617 | 2.9152 | -3.0749 | -34.911 | -75.3804 | -112.7988 | QC'd by BOC Sciences | |||||||||||||||
| Inhibitor | 8.9552 | 108.0611 | 43 | Partial curve; high efficacy | -5.0479 | 2.7202 | 0.9893 | -109.0611 | -1 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -113.6053 | -2.5498 | -0.0161 | -0.9054 | 1.549 | -1.6624 | -1.035 | -0.2871 | -3.0955 | -5.3823 | -47.9419 | -113.6053 | QC'd by Prestwick | |||||||||||||||
| Inhibitor | 14.5649 | 127.9559 | 42 | Partial curve; high efficacy | -4.8367 | 1.2475 | 0.9826 | -128.4559 | -0.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -105.9867 | 2.2922 | -1.3033 | 0.0604 | 0.3327 | 1.033 | 1.7306 | -15.2556 | -2.8882 | -32.157 | -68.6091 | -105.9867 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 14.9492 | 98.1954 | 42 | Partial curve; high efficacy | -4.8254 | 1.21 | 0.9903 | -97.6954 | 0.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.6094 | 2.6726 | 2.2733 | -2.4477 | -0.1168 | -0.6014 | -1.3047 | -4.1854 | -5.4249 | -37.0086 | -59.94 | -86.6094 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 16.3421 | 115.9287 | 42 | Partial curve; high efficacy | -4.7867 | 1.4163 | 0.997 | -118.4287 | -2.5 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -99.1865 | 0.721 | -0.0234 | -3.3938 | -3.533 | -1.967 | -3.116 | -5.2659 | -9.9377 | -23.4562 | -59.675 | -99.1865 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 23.0839 | 90.5675 | 41 | Partial curve; high efficacy | -4.6367 | 4.095 | 0.9634 | -90.5675 | 0 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -83.3955 | 4.7449 | 7.5777 | 1.4772 | 1.3021 | 1.667 | 0.6907 | -1.2401 | -5.9881 | -10.181 | -16.7566 | -83.3955 | QC'd by Specs | |||||||||||||||
| Inhibitor | 23.0839 | 75.774 | 41 | Partial curve; partial efficacy | -4.6367 | 4.095 | 0.992 | -75.274 | 0.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -69.5257 | 0.3468 | 1.3292 | 2.013 | 2.535 | 1.636 | -1.8741 | -0.1993 | 1.5465 | -2.9321 | -17.123 | -69.5257 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 16.3421 | 92.0577 | 41 | Partial curve; high efficacy | -4.7867 | 1.6924 | 0.9944 | -95.1547 | -3.097 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -84.8081 | -1.7048 | -2.7043 | -2.7328 | -3.1309 | -0.9142 | -2.2389 | -6.802 | -4.7221 | -18.0355 | -46.4212 | -84.8081 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 25.9005 | 68.5187 | 40 | Partial curve; partial efficacy | -4.5867 | 4.095 | 0.9879 | -72.9929 | -4.4742 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -67.4188 | -3.157 | -0.3952 | -2.6752 | -3.6727 | -6.2029 | -4.4808 | -5.843 | -6.458 | -7.6543 | -12.7605 | -67.4188 | QC'd by Sequoia | |||||||||||||||
| Inhibitor | 18.3362 | 42.3769 | 21 | Partial curve; partial efficacy | -4.7367 | 1.4163 | 0.9611 | -43.3769 | -1 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -38.05 | -3.369 | -1.8439 | -1.2546 | 0.0268 | -0.6973 | -0.0993 | 0.3038 | 0.0057 | -12.0993 | -17.8476 | -38.05 | QC'd by Microsource | |||||||||||||||
| Inhibitor | 20.5735 | 54.323 | 21 | Partial curve; partial efficacy | -4.6867 | 2.2526 | 0.9506 | -54.823 | -0.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -53.748 | 5.1019 | 2.1979 | 0.0674 | 0.0829 | -1.1077 | 0.4012 | -3.1391 | -4.7207 | -8.4582 | -17.4267 | -53.748 | QC'd by Sytravon | |||||||||||||||
| Inhibitor | 18.3362 | 46.347 | 21 | Partial curve; partial efficacy | -4.7367 | 1.6259 | 0.9854 | -44.347 | 2 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -38.9009 | 2.9787 | 1.9491 | 2.1848 | 2.7358 | 2.041 | 2.2567 | 2.6921 | -0.4112 | -6.8174 | -16.7494 | -38.9009 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 14.5649 | 50.0996 | 21 | Partial curve; partial efficacy | -4.8367 | 1.21 | 0.992 | -51.0996 | -1 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -41.7421 | 0.7762 | -0.4111 | -2.9919 | -2.3469 | -1.1566 | 0.2368 | -2.4226 | -3.9572 | -14.3837 | -27.3644 | -41.7421 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 20.5735 | 41.1229 | 20 | Partial curve; partial efficacy | -4.6867 | 2.3332 | 0.9549 | -41.1229 | 0 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -40.3166 | 0.9429 | 4.3053 | 1.2929 | -3.0207 | 0.3603 | 0.3042 | -0.5695 | -2.7371 | -4.0541 | -12.0009 | -40.3166 | QC'd by Sytravon |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |
| 20 | IC50 | < | 20000 | nM |